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ABSTRACT OF DISSERTATION 
 
 
MECHANISMS OF CD4+ T CELL 
APOPTOSIS AND THE ROLE OF ETHANOL 
AS A COFACTOR IN HIV PATHOGENESIS 
 
Acquired Immunodeficiency Syndrome (AIDS) was first reported in the United 
States in 1981 and has since become a major worldwide epidemic. The typical course of 
HIV disease begins with a primary infection followed by a relatively long latency phase 
and finally ends in the advance phase also called AIDS. There are two aspects considered 
the most important in HIV pathogenesis, namely viral replication and CD4+ T cell 
depletion. 
During the latency phase, tumor necrosis factor α (TNFα) has been shown to play 
a predominant role in HIV-1 replication and disease progression. Since ethanol is also an 
important risk factor and has been implicated in HIV-1 replication, we investigate the 
effects of ethanol on TNFα inducible signaling associated with HIV-1 replication in 
human CD4+ T cells. We demonstrate that clinically relevant ethanol concentrations 
significantly potentiate TNFα inducible NFκB. Although ethanol effectively collaborated 
with TNFα, by itself it does not have a direct effect on NFκΒ activation. The ethanol 
dependent potentiation of TNFα inducible NFκB nuclear translocation is observed to 
involve the enhanced degradation of IκBα. Additionally, the ethanol mediated 
potentiation of TNFα inducible NFκB activation is abrogated by the known antioxidant 
pyrrolidinedithiocarbamate (PDTC), suggesting an important mechanistic role for 
reactive oxygen species (ROS) in this process. In correspondence with its effect on
NFκB, ethanol is also able to significantly enhance HIV-1 long terminal repeat (HIV-1-
LTR) dependent transcription induced by TNFα.   
Apoptosis has been proposed as a critical mechanism for CD4+ T cell depletion in 
HIV pathogenesis. Ceramide, a sphingolipid metabolite, is a common apoptotic 
transducer involved in CD4+ T cell apoptosis. In the current study, we show that 
ceramide potently induces CD4+ T cell apoptosis through activating caspase 3, which 
may further increase Fas Ligand expression to amplify the apoptotic signaling. 
Interestingly, the apoptotic effect of ceramide is completely blocked by pretreatment with 
zinc and the underneath mechanism is suggested to be a direct inhibition of caspase 3 
activity by zinc. 
Survival factors are equally important in the regulation of apoptotic process. We 
demonstrate that PI3-kinase/Akt pathway is indispensable for the survival of CD4+ T 
cells. Further, Akt kinase is significantly inactivated and downregulated in oxidative 
stress induced CD4+ T cell apoptosis. N-acetyl-cysteine (NAC) can rescue CD4+ T cell 
from H2O2 induced caspase 3 activation and apoptosis, while depletion of glutathione 
(GSH) exacerbate it.  
Overall, this work identifies several mechanisms underlying CD4+ T cell 
apoptosis and provides molecular basis for the role of ethanol as a cofactor that can 
adversely affect HIV-1 infection and pathogenesis. 
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Chapter One 
 
General Introducion and Literature Review 
 
Disease Course of HIV infection 
It has been almost seventeen years since human immunodeficiency virus (HIV) 
was identified as the cause of acquired Immunodeficiency syndrome (AIDS). However, 
we still have a long way ahead to fully understand how HIV kills its target, the CD4+ T 
cell, and how this killing cripples the immune system. AIDS is the end-stage disease of 
HIV infection. The key to understanding its pathogenesis lies in elucidating the course of 
infection and the virus-host relation in the years preceding terminal illness (Weiss, 1993). 
Generally, HIV disease propagation can be categorized into three different stages: the 
primary HIV infection, the clinical latent period and the advanced stage or AIDS 
(Pantaleo and Fauci, 1994). 
The period of primary HIV infection is characterized by those virological and 
immunological events that reflect the initial spreading and dissemination of HIV, the 
emergence of HIV-specific immune responses and the down-regulation of viremia 
(Graziosi, 1993). Further, the primary HIV infection stage has been divided empirically 
into two periods. One is the spreading and dissemination of HIV and the other is the 
partial clearance of virus from peripheral blood. The viral dissemination period 
corresponds to the first two or three weeks of infection and is highlighted by a peak in 
viremia (Fig. 1). In the initial establishment stage of infection, the immune activation, 
which is necessarily associated with the generation of an antigen-specific immune 
response, may actually work in favor of the virus. A group of cytokines including 
interleukin (IL)-1, IL-6, tumor necrosis factor (TNF)-α and TNF-β, which are released by 
certain immunocompetent cells that are recruited to the primary anatomic site of virus 
localization (lymphoid organs), may further enhance the virus replication. Also, activated 
antigen-specific CD4+ T lymphocytes could serve as ideal targets for supporting high 
levels of viral replication (Reimann, 1994). Following the peak of viremia, all parameters 
of virus replication are significantly down-regulated in peripheral blood. At the same  
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Figure 1.  Schematic course of HIV infection
3
  
 
time appears the HIV-specific immune response (Clark, 1991). Both cell-mediated and 
humoral HIV-specific immune responses contribute to the down-regulation of viremia. 
HIV-specific cytotoxic T cells are primarily involved in the elimination of HIV infected 
cells, whereas HIV-specific antibodies are mainly responsible for the clearance of viral 
particles from the circulation (Pantaleo, 1994). The immune response against HIV is 
extremely powerful and is clearly more effective than any of the therapeutic approaches 
currently available in controlling virus replication. However, the HIV specific immune 
responses are unable to completely clear the virus. Reports show that active virus 
replication occurs in lymph nodes at any given time during HIV infection (Pantaleo, 
1991). There are two potential explanations for the failure of the immune response to 
totally eliminate the infection. First, the HIV specific immune response is inherently 
inadequate. Second, the immune responses are adequate but HIV is able to escape the 
immune response. There is some evidence for the second explanation. HIV may 
potentially escape elimination by the immune system via two possible mechanisms: first, 
latently HIV infected cells may not be eliminated by HIV specific CTL; secondly, virus 
particles trapped in the follicular dendritic cell (FDC) network serve as a continuous 
source of virus for de novo infection of CD4+ T lymphocytes which are migrating 
through the lymphoid organs.  
The predominantly virological phenomenon of the clinically latent period is the 
dichotomy in viral burden and viral replication between peripheral blood and lymphoid 
tissue. Sequestration of infected cells and trapping of virions in the FDC network are 
responsible for this dichotomy (Pantaleo, 1991; Embretson, 1993; Pantaleo, 1994). 
Importantly, the general state of immune activation is the most striking immunological 
phenomenon in this stage. Latently HIV infected cells and trapped virions may be crucial 
for the propagation of infection over time and they are key factors to maintain a persistent 
stimulation of the immune system. Both T and B cell lineages are stimulated. Chronic 
stimulation of the immune system creates favorable conditions for HIV replication and 
virus dissemination. It has been proposed that virus-CD4 interaction relays a negative 
signal to the target cell, which may eventually induce cellular unresponsiveness (i.e. 
anergy) (Mittler, 1989; Linette, 1988; Amadori, 1992) or prime the cell to undergo 
apoptosis (Terai, 1991; Groux, 1992; Laurent-Crawford, 1991; Gougeon, 1991; Meyaard, 
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1992). Defective production of cytokines such as IL-2 is associated with the quantitative 
and qualitative defects of CD4+ T lymphocytes and may contribute to the impairment of 
other cells (i.e. CD8+ cells) (Shearer, 1991). In contrast to IL-2, other cytokines such as 
IL-1, TNF-α,  TNF-β and IL-10, which may either potentiate virus replication or inhibit a 
variety of immune functions, are overproduced (Poli, 1992; Del Prete, 1993; Clerici, 
1994). The general state of immune activation may be the major mechanism for the 
induction of apoptosis. Apoptosis may be readily detected in lymph nodes of HIV 
infected individuals at different stages of disease and several cell types including CD4+, 
CD8+ and B cells are involved in this process. The degree of apoptosis detected in the 
tissue seems to correlate with the state of immune activation rather than viral burden or 
disease stage (Meyaard, 1994). It is conceivable that the multiple mechanisms mentioned 
above contribute directly or indirectly to the progressive degeneration (i.e. follicular 
involution and extensive fibrotic and fatty infiltration) of the lymphoid tissue that is the 
main reason for the severe immune dysfunction. 
In the advanced stage of disease, severe immunosupression is the final result of 
the systemic process of HIV disease. This process involves every component of the 
immune system and leads to its destruction. During this stage there is a re-equilibration of 
the levels of viral burden and replication between peripheral blood and lymph node 
(Pantaleo, 1991). This re-equilibration and high levels of viremia reflect both the 
complete removal of those mechanisms of HIV sequestration in the lymphoid system and 
the collapse of the HIV specific immune response.  This collapse of immune system is 
not limited to HIV- specific immune response but is generalized and results in 
widespread failure of immune responses against other invading pathogens. Symptoms 
frequently seen include prolonged fatigue, fever, swollen gland (lymph nodes), skin rash 
or lesion, frequent diarrhea and tumor (Kaposi sarcoma) etc. 
 
Apoptosis 
 
 In multicellular organisms, homeostasis is maintained through a balance between 
cell proliferation and cell death. Once development is complete, the viability of the 
organism depends on the maintenance and renewal of the diverse set of differentiated cell 
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types. Different cell types vary widely in the mechanisms by which they maintain 
themselves over the life of the organism (Thompson, 1995). For example, blood cells 
undergo constant renewal from hematopoietic progenitor cells. In contrast, neural cells 
have at best a limited capacity for self-renewal, and most neurons survive for the life of 
the organism. Within each cell type, the control of cell number is determined by a 
balance  between cell proliferation and cell death. The differentiated cells of multicellular 
organisms all appear to share the ability to carry out their own death through an internally 
encoded death program (Raff, 1992). This characteristic form of cell death called 
programmed cell death or apoptosis. Apoptosis can be triggered by a variety of intrinsic 
and extrinsic signals and allows for the elimination of cells that have been produced in 
excess, that have developed improperly, or that have sustained genetic damages. 
 
Apoptosis and necrosis 
 
Apoptotic cell death can be distinguished from necrotic cell death (Wyllie, 1980). 
Necrosis is a pathologic form of cell death resulting from acute cellular injury, which is 
typified by rapid cell swelling and lyses. In contrast, apoptosis is characterized by 
controlled autodigestion of the cell. The activation of endogenous proteases results in 
cytoskeletal disruption, cell shrinkage and membrane blebbing. Apoptosis is also 
characterized by the unique changes in the nucleus. The nucleus undergoes condensation 
as endonucleases are activated and begin to degrade nuclear DNA. In many cell types, 
DNA is chopped into DNA fragments the size of oligonucleosomes, whereas in others 
larger DNA fragments are produced. Apoptosis is also accompanied by a loss of 
mitochondrial function. This has led to speculation that mitochondria may play an 
important role in the regulation of apoptosis. The dying cell maintains its cell membrane 
integrity. However, alterations in the plasma membrane of apoptotic cells signal 
neighboring phygocytic cells to engulf them and thus to complete the degradation process 
(Ellis, 1991; Hall, 1994). Apoptotic cells which has not been engulfed immediately 
breakdown into smaller membrane-bound fragments called apoptotic bodies. An 
important feature of apoptosis is that it results in the elimination of the dying cell without 
induction of an inflammatory response (Thompson, 1995). In contrast necrotic cell death 
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is associated with an early loss of cell membrane integrity, resulting in leakage of 
cytoplasmic contents and the induction of an inflammatory reaction. Necrosis is often 
induced by agents that damage cell membranes (i.e. heat) or that interfere with oxidative 
phosphorylation (i.e. ischemia). The complete or virtual absence of normal cellular detail 
is due to protein denaturation and nuclear dissolution. Unlike apoptosis, necrosis does not 
require gene expression, and the cells die as a result of cell membrane or ion pump 
damage (Staunton, 1998). Ultrastructurally, the necrotic cell initially swells because cell 
membrane volume control is lost. The cell then lyses, organelles disintegrate, and with 
nuclear dissolution, there is rarely DNA degradation. The cytoplamic contents of lysed 
necrotic cells activate an inflammatory response. Eventually, necrotic material may be 
removed by macrophages, but persistent inflammation and scarring or cavitation cause 
irreversible local tissue damage.  
 
Disorders caused by increased cell survival 
 
Diseases characterized by the accumulation of cells include cancer, autoimmune 
diseases and certain viral illness. Cell accumulation can result from either increased 
proliferation or the failure of cells to undergo apoptosis. Cells from a wide variety of 
human malignancies have a decreased ability to undergo apoptosis in response to at least 
some physiologic stimuli (Hoffman, 1994). This is most apparent in metastatic tumors. 
Most normal cells depend on environment specific factors to maintain their viability. This 
dependence may serve to prevent normal cells from surviving in the nonphysiologic sites. 
Metastatic tumor cells have detoured from this homeostatic mechanism and can survive 
at sites distinct from the tissue in which they arose. Apoptosis is modulated by a large 
number of evolutionarily conserved oncogenes and tumor suppressor genes. The Bcl-2 
gene product is a potent inhibitor of apoptosis. Bcl-2 is homologous with the anti-
apoptotic gene ced-9, which regulates cell death in C elegans (Hengartner, 1994). Bcl-2 
was first discovered as a result of its location at the site of a translocation between 
chromosomes 14 and 18 and is present in most human follicular lymphomas (Bakhshi, 
1985). It is suggested that B lymphocytes accumulate in follicular lymphoma because of 
prolonged survival rather than increased proliferation (Vaux, 1988). Bcl-2 is only one 
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member of a family of genes that control the apoptotic threshold of a cell (Boise, 1993). 
At least 15 Bcl-2 family members have been identified in mammalian cells. All members 
possess at least one of the four conserved motifs known as Bcl-2 homology domains 
(BH1 to BH4). Most pro-survival members, which can inhibit apoptosis induced by a 
wide variety of cytotoxic stimuli, contain at least BH1 and BH2 or even all four BH 
domains like Bcl-2 (Adams, 1998). In the pro-apoptotic members of Bcl-2 family, BH3 
domain is essential for the function of the killers (Kelekar, 1998). Pro- and anti-
apoptotic family members can heterodimerize and seemingly titrate one anothers 
function, implying that their relative concentration may act as a rheostat for the suicide 
program (Oltvai, 1993). In tumor cell lines, overexpression of Bcl-2 or of the related gene 
Bcl-x has been found to confer resistance to cell death in response to chemotherapeutic 
agents such as cytosine arabinoside and cisplatin (Miyashita, 1993). These results are 
surprising because chemotherapy was previously thought to kill tumor cells by inducing 
irreversible metabolic damage that results in target cell necrosis. It currently looks like 
that the primary mechanism by which most chemotherapeutic agents induce cell death is 
via creating cellular aberrations in cellular physiology that result in the induction of 
apoptosis. Bcl-2 is considered a downstream regulator of apoptosis because it inhibits 
apoptosis induced by a variety of stimuli, including gamma irradiation, hyperthermia, 
chemotherapeutic agents, and corticosteroids. Thus, Bcl-2 expression is one of several 
well-defined anti-apoptotic forces. Bcl-2 homologs interact closely in the regulation of 
apoptosis. The Bcl-2/Bax ratio is the critical determinant for the induction and inhibition 
of apoptosis. When Bax is in excess, the integrated signal favors apoptosis, and while 
Bcl-2 is dominant, apoptosis is blocked (Oltvai, 1993).  
The tumor suppressor gene p53 encodes a transcription factor normally 
maintained in low levels. The high frequency with which p53 is functionally inactivated 
in various human cancers attests to its pivotal role as a terminator against expansion of 
mutated somatic cells. In many cases, p53 itself is mutated or deleted. Normally, DNA 
damage can induce p53 activation. Two cellular responses to p53 activation are growth 
arrest and apoptosis. Which of these two prevails depend on cell type, cell environment 
and other factors as well (Evan, 1998). Substantial evidence suggests that a major part of 
p53-mediated growth arrest proceeds through induction of the cyclin-dependent kinase 
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(Cdk) inhibitor p21 (Hansen, 1997). Cells with sustained DNA damage were held in G1 
for DNA repairs. If the damage is successfully repaired, the growth arrest can be 
reversed. If DNA damage is irreparable, the cell undergoes apoptosis.  This is referred to 
as (p53-mediated) DNA damage-induced apoptosis. In cells lacking functional p53, there 
is reduced susceptibility to radiation and cytotoxic drug induced apoptosis (Lowe,1993). 
Cells with inactivated p53 might therefore survive and allow further genetic damage to 
convey and accumulate. Errors in the repair of DNA damage that might otherwise induce 
apoptosis could contribute to the high mutation rate observed in many human 
malignancies. The mechanism by which p53 promote apoptosis is still unclear. Some 
studies suggests multiple p53 targets such as Bcl-2 antagonist Bax (Yin, 1997), the 
insulin-like growth factor-I (IGF-I) receptor (Prisco, 1997), and components of the renin-
angiotensin system ( Pierzchalski, 1997).  
C-Myc, the protein encoded by the c-myc oncogene, is a transcription factor, 
which is normally induced following mitogenic stimulation. C-Myc is required for the 
cell cycle entry and promotes cell proliferation. However, c-Myc induces apoptosis when 
insulin-like growth factor and platelet-derived growth factor (PDGF), which normally 
suppress c-Myc-induced apoptosis, are not available (Evan, 1992). It has been proposed 
that when c-Myc is active, there is simultaneous induction of proliferation and apoptosis. 
The apparently paradoxical coupling of cell proliferation and apoptosis may serve as a 
safe-guard against neoplasia. Successful proliferation requires a dual signal: one will 
override the apoptotic signal and the other will promote growth (Evan, 1996). 
Interestingly, IGF, PDGF and Bcl-2 are all able to inhibit c-Myc-induced apoptosis 
independently of cell proliferation. 
Physiologic regulation of cell death is essential for the removal of potentially 
autoreactive lymphocytes during development and for the removal of excess cells after 
the completion of an immune response. Failure to remove autoimmune cells can result in 
autoimmune disease. Recent works in animal model system have clearly demonstrated 
the importance of dysregulated apoptosis in the etiology of autoimmune disease. One 
molecule, which is critical in lymphocytes, is the cell surface receptor Fas, a member of 
the tumor necrosis factor (TNF) receptor family. Stimulation of Fas on activated 
lymphocytes can induce apoptosis. Two forms of hereditary autoimmune disease have 
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been attributed to alterations in Fas-mediated apoptosis. MRL-lpr mice, which develop 
fatal systemic lupus erythematosus by 6 month of age, have a mutation in the Fas 
receptor. In contrast, the GLD mice, which develop a same illness, have a mutation in the 
Fas ligand (Suda, 1993). In human, a secreted form of Fas has been discovered (Cheng, 
1994). Patients with systemic lupus erythematosus have elevated levels of soluble Fas, 
which may competitively inhibit Fas ligand-Fas interactions. The resulting decrease in 
Fas-mediated apoptosis may contribute to the accumulation of autoimmune cells in this 
disorder. A lupuslike autoimmune disease has also been reported in transgenic mice 
constitutively overexpressing Bcl-2 in their B cells (Strasser, 1991).  
 
Disorders caused by excess cell death 
 
Excessive cell death can result from acquired or genetic conditions that enhance 
the magnitude of the apoptotic signals or reduce the threshold at which such events 
induce apoptosis. Although increased apoptotic cell death has been reported in a number 
of diseases, the underlying mechanism has not been fully defined.  
A wide variety of neurodegenerative diseases are characterized by the gradual 
loss of specific sets of neurons (Isacson, 1993). Such disorders include Alzheimers 
disease, Parkinsons disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, 
spnal muscular atrophy and various forms of cerebellar degeneration. In these diseases, 
cell death results in specific disorders of movement and central nervous system function. 
The cell loss in these diseases does not involve an inflammatory response, and apoptosis 
appears to be the mechanism for the cell death. Oxidative stress, calcium toxicity, 
mitochondria defects and deficiency of survival factors have all been postulated to 
contribute to the pathogenesis of these diseases (Ziv, 1994). Each of these pathways 
predisposes neurons to apoptosis both in vivo and in vitro. Overexpression of Bcl-2 
decreases the neurotoxicity of each of these potential inducers of cell death (Zhong, 
1993). Neurtrophic growth factors and the extracellular matrix also change the apoptotic 
threshold of neural cells. In summary, these data suggest a model in which the threshold 
for cell death is dynamically regulated. The apoptotic threshold of a cell is thus 
determined by the combined effects of external and internal survival factors. 
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AIDS, which is induced by the human immunodeficiency virus (HIV), is probably 
the most dramatic example of virus-associated cell depletion. The development of AIDS 
has been directly correlated with the depletion of the CD4+ T cells, the cellular targets of 
viral infection. It has been shown that CD4 acts as a receptor for viral attachment, thus 
facilitating HIV infection of CD4+ T cells. Surprisingly, most T cells that die during HIV 
infection do not appear to be infected with HIV. One important point is that why the virus 
would develop a mechanism to selectively deplete its host cell. The possible explanation 
may be that CD4+ T cells have a crucial function in establishing protective immune 
responses against the viral infection. The establishment of a chronic HIV infection may 
therefore depend on virally mediated depletion of CD4+ T cells and the concomitant loss 
of the protective immunity. Viral replication itself may not be limited by this form of 
CD4-dependent cell death, because the virus may specifically down-regulates the CD4 
receptor on infected cells (Littman, 1994). We are going to further talk about the relation 
between HIV infection and apoptosis in detail in the following section. 
 
Apoptosis and CD4+ T cell depletion in HIV pathogenesis 
 
One intriguing puzzle in HIV pathogenesis is that how HIV kills its target, the 
CD4+ T cells? It appears that killing its major host cell and viral factory may be 
considered as a non-adaptive survival strategy. So does HIV really kill the cell it has 
infected? There is no clear-cut answer for this question. But more and more evidence is 
leaning toward the hypothesis that indirect killing of bystander cells may be the main 
mechanism accounted for the depletion of CD4+ T cells in HIV pathogenesis. More than 
90% of CD4+ T lymphocytes reside in the lymphoid tissues. Even during the so-called 
clinically latent phase of the disease, when the number of CD4+ T lymphocytes in the 
peripheral blood remains at a steady level and the amount of HIV in the blood remains 
low, there is massive and persistent infection in the lymphoid tissues (Veazey, 1998). 
During the course of infection, there is a steady depletion of CD4+ T lymphocytes and the 
structure of the lymphoid tissue is progressively destroyed. In the final stage of the 
disease, the immune system is severely impaired and the lymphoid architecture is totally 
destroyed with complete loss of cellularity and replacement by fibrotic tissue (Pantaleo, 
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1994). Another major site of HIV infection is the central nervous system (CNS) where 
atrophy and other structural damage to the CNS are observed in AIDS dementia patients 
(Dal Pan, 1992).  
Several reports showed that HIV infection, at least in vitro, directly induces 
apoptosis of the CD4+ T lymphocytes (Scarmato, 1996). Cytotoxic T lymphocytes (CTL) 
could play an important role in killing of HIV-infected cells during early stages of 
infection (Borrow, 1994). Other reports suggested that perturbation of host-cell 
membranes could be the primary mechanism of HIV cytopathology (Cloyd, 1991). 
Despite the above reports, there is increasing evidence in favor of indirect killing of 
bystander cells by extracellular or cell surface-associated components of HIV infected 
cells. This could explain why there is such massive death of CD4+ T lymphocytes during 
the course of HIV infection when the viral burden is comparatively low (Ascher, 1995; 
Anderson, 1998). The dramatic decline in the number of CD4+ T cells during the course 
of HIV infection points to the death of large numbers of uninfected bystander cells. A 
number of studies reported that the majority of CD4+ cells undergoing apoptosis during 
HIV infection are uninfected (Finkel, 1995; Su, 1995). In lymph nodes from HIV-
infected children, apoptosis occurs predominantly in uninfected bystander cells and not in 
productively infected cells (Finkel, 1995). Cocultureing of HIV-infected cells with 
uninfected cells resulted in apoptosis of the uninfected cells prior to syncytium formation 
or establishment of productive viral infection (Nardelli, 1995). It has recently been shown 
that chronically HIV-infected monocytic cells secrete a low molecular weight soluble 
factor that induces apoptosis in cocultured T cells (Chen, 1998). Addition of supernatant 
from HIV-1 infected dendritic cells to unfractionated thymocytes dramatically decreased 
their viability suggesting that thymocyte killing could be mediated by a soluble factor 
released from dendritic cells (Beaulieu, 1996). The HIV envelop protein gp120 in 
solution or on the surface of HIV-infected cells has been implicated in the induction of 
cell death and cytotoxicity. Cross-linking of CD4 by gp120 immune complex in vitro 
leads to T cell apoptosis by activation induced cell death (AICD) (Banda, 1997; Banda, 
1992; Oyaizu, 1993). As seen in Fig. 2, the infected cell expresses gp120/gp41 on its 
surface and is producing virus. Expression of CD4 has been down-regulated on the 
infected cell. Ligation of CD4 on the uninfected bystander cell by virion or by gp120 
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delivers an inhibitory signal. Subsequent ligation of T cell receptor (TCR) on the 
uninfected cell by mitogen (or antigen or superantigen) leads to apoptosis. In contrast, 
TCR ligation of the infected cells by mitogen leads to increased viral replication and cell 
division. gp120 has also been implicated in causing death of neurons, CD8+ cells and the 
hematopoietic progenitor cells. Interestingly, lack of gp120-induced anergy and apoptosis 
in chimpanzees protects them from progression to AIDS (Banda, 1996). The role of HIV 
regulatory protein Tat in the induction of apoptosis in bystander cells is also documented 
(Li, 1995). Fas/FasL interaction may also play an important role in lymphocyte apoptosis 
in HIV disease (Estaquier, 1996).  
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Figure 2. Productively infected CD4+ T cells induce apoptosis of bystander 
 uninfected CD4+ T cells. The infected cell expresses gp120/gp41 on its  
surface and is producing virus. Expression of CD4 has been down-modulated  
on the infected cell. Ligation of CD4 on the uninfected cell by virion (a) or  
by gp120 (b) delivers an inhibitory signal. Subsequent ligation of the TCR  
on the uninfected cell by mitogen (or antigen or superantigen) leads to apoptosis.  
In contrast, TCR ligation of the infected cell by mitogen leads to increased viral 
 replication and cell division 
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While contributing to the bystander effect, HIV could also have devised strategies to 
evade death of infected cells. Inhibition of apoptosis in HIV-infected cells promotes viral 
production and facilitates persistent infection. Finkel et al. (Finkel, 1995) showed that in 
HIV-infected lymph nodes HIV-infected cells were very rarely apoptotic, while there was 
widespread apoptosis in uninfected cells. Some studies suggested that viral proteins 
inside infected cells including Tat and Nef might inhibit apoptosis (Giellini, 1995; Guy, 
1987). 
 
NFκB and HIV disease 
 
HIV infection leads to the progressive loss of CD4+ T cells and the near complete 
destruction of the immune system in the majority of infected individuals. High level of 
viral gene expression and replication result partially from the activation of NFκB 
transcription factors, which in addition to orchestrating the host inflammatory response 
also activate the HIV-1 long terminal repeat (LTR). Transcription of the HIV-1 genome 
depends on the intracellular environment into which the virus integrates and is regulated 
by a complex interaction between viral regulatory proteins and cellular transcription 
factors that interacts with the viral LTR region (Gaynor, 1992). Sequences involved in 
viral gene expression are contained within U3 and R regions of the HIV-1 LTR and may 
be subdivided into the core promoter elements, the enhancer, the modulatory and 
negative regulatory elements, and the Tat responsive element (TAR). The most widely 
studied element in the modulatory region of the HIV-1 LTR is the enhancer region. 
Which consists of two 10-bp conserved sequences (-109 to 79) known as NFκB motifs. 
The role of NFκB in controlling the HIV-1 LTR transcription was first established by 
demonstrating a direct correlation between increases in NFκB DNA binding activity and 
HIV-1 LTR-directed transcriptional activity during T cell activation (Nabel, 1987). 
Mutation of NFκB motifs in HIV-1 LTR chloramphenicol acetyltransferase reporter 
constructs results in a marked decrease in gene expression following transfection into 
lymphoid cells, in both presence and absence of the tat gene. Transient transfection 
studies, with combinations of the HIV-1 LTR and HIV-1 enhancer sequences linked to 
reporter genes, demonstrate that induction of NFκB DNA binding activity in T cells and 
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monocytes leads to increased HIV-1 LTR-directed gene expression (Grilli, 1993). The 
NFκB sites act in synergy with NF-AT sites in phorbol myrisstate acetate (PMA)-
stimulated T cells to increase the rate of viral replication in cells that respond to 
mitogenic stimulation (Du, 1993; Stevenson, 1990). Among the elements identified as 
positively acting factors in basal HIV-1 transcription, TATA, Sp1 and NFκB elements 
are the most influential in primary monocytes while NFκB and NF-AT have strong 
effects in activated T cells (Moses, 1994). 
NFκB activation represents a double-edged sword in HIV infected cells. It 
mediates immune response and also leads to enhanced HIV-1 transcription. NFκB has 
also been implicated in apoptotic signaling. It promotes apoptosis under some 
circumstances, but acts as a survival factor under other circumstances. Therefore, 
activation of NFκB may have impact upon HIV pathogenesis at many levels and their 
relationship is multi-faceted (Deluca, 1999). 
 
Oxidative stress and HIV 
 
Several recent papers have proposed that apoptosis is the cause of immune-cell 
loss in patients infected with HIV. The process of apoptosis and latent virus activation 
may be linked to oxidative stress in HIV infection. An excessive production of reactive 
oxygen species (ROS) and a broad deficiency of antioxidant in the course of HIV 
infection, lend strong support for the premise that ROS exist in HIV infection and AIDS. 
This warrants a closer examination of the actual mechanisms by which ROS may initiate 
apoptosis. Moreover, an understanding of how certain antioxidants act to mitigate 
oxidative stress and interact with apoptotic process may well provide a contributory 
therapeutic approach.  
ROS are normal products of phagocytic activity and cellular respiration. Any 
antigenic or regulatory stimulus to polymorphonuclear leukocytes, or T cell activity, will 
increase the expression of ROS (Buttke, 1994). Thus, the high level of antigenic and 
cytokine activity in HIV/AIDS results in the production of substantial levels of 
superoxides, hydrogen peroxide and hydroxyl radials. Furthermore, macrophages and 
monocytes produce tumor necrosis factor (TNF) in response to free radical activity and 
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this is found in excess in patients with HIV/AIDS (Johnston, 1978; Tracey, 1989). TNF 
may play an important role in causing a further increase in the ROS production by: (1) 
providing an amplification loop that feeds back to excite further production of ROS from 
macrophages and neutrophiles (Clark, 1988); and (2) reacting with T cells to enhance 
expression of autocrine cell activators, such as interleukin (IL)-2 and receptors, thereby 
promoting activation of T cell respiratory activity and an increase in intracellular ROS 
(Scott-Algara, 1991).  
The loss of antioxidant defenses is critical to the development of ROS in patients 
with HIV/AIDS. It may result directly from the effects that excessive production of ROS 
overwhelms available antioxidants. Other indirect causes may include compromised 
gastrointestinal integrity, which results in mal-absorption of nutrients, alternation of 
systemic amino acids, which results in glutathione deficiency, and loss of electron-
transport capacity, which causes the loss of NADPH (Greenspan, 1994).  
The mechanisms of oxidant-mediated cell injury may include: (1) membrane-lipid 
peroxidation and loss of Ca2+ homeostasis. (2) DNA damage (3) Alteration of metabolic 
pathways/loss of ATP. 
 
Sphingomyelin (SM) pathway and HIV disease 
 
The sphingomyelin pathway is a ubiquitous and evolutionarily conserved 
signaling system. Ceramide, the central molecule in this pathway, serves as a second 
messenger for a wide range of cellular functions from proliferation and differentiation to 
growth arrest and apoptosis. In HIV infected individuals, lymphocyte apoptosis may 
signal T cell depletion and disease progression. It has been shown that circulating 
populations of CD4+ and CD8+ T cells from HIV-infected patients display large increases 
in ceramide content and apoptosis as compared with a normal population (Dimarzio, 
1997; Cifone, 1997). Also, ceramide levels are markedly elevated in HIV-infected CEM 
cells (Van Veldhoven, 1992). Treatment of HIV-infected HL-60 cell (Rivas, 1994) or the 
latently infected myelomonocytic cell line U-1IIIB and OM-10.1 (Papp, 1994) with 
ceramide analogues profoundly increased viral production. Alternatively, treatment of 
HIV-infected patients with L-carnitine, which reduced acid Smase activity, significantly 
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reduced ceramide levels in peripheral blood mononuclear cells, and correlated with a 
decrease in the number of apoptotic CD4+ T cells (Cifone, 1997). The underlying 
mechanism and therapeutic potential need further investigation. 
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Chapter Two  
 
The Role of Ethanol as a Cofactor in HIV Pathogenesis 
 
Introduction 
An important clinical feature of HIV-1 infection is a long period of latency that 
precedes the development of acquired immunodeficiency syndrome (AIDS) (Melbye, 
1986; Fauci, 1988; Embretson, 1993). In latently infected cells, the HIV-1 integrated 
provirus may exist in an inactive state until the appropriate activation signals cause 
stimulation of viral transcription.  During an HIV-1 infection, a number of cellular factors 
are induced that can modulate the replication of the latent virus.  Among these host 
cellular factors, proinflammatory cytokines induce virus replication (Folks, 1987; Poli, 
1993; Fauci, 1996), while certain other cytokines have an inhibitory or downregulatory 
effect on HIV-1 replication (Schuitemaker, 1992; Poli, 1991). Of the HIV-1 inducing 
cytokines, TNFα is the most potent, and is an important regulator of HIV-1 expression in 
chronically infected T lymphocytes, primary monocytes, and monocytic cell lines (Folks, 
1989; Michihiko, 1989; Matsuyama, 1991; Mellors, 1991).  
TNFα stimulated HIV-1 expression is mediated by the transcription factor NFκB 
which binds to the NFκB transcription enhancer motifs in the HIV-1 5 long terminal 
repeat (LTR) (Duh 1989). Although other mammalian transcription factors participate in 
the regulation of the HIV-1 LTR transcriptional activation (Steffy, 1991; Garcia, 1994), 
NFκB plays a predominant role in TNFα induced LTR-driven transcription (Duh, 1989; 
Osborn, 1989; Schreck, 1991; Rattner, 1993). NFκB is a member of the NFκB/Rel family 
of dimeric transcription factors, and it regulates the expression of numerous cellular 
genes, particularly those involved in the immune and inflammatory responses (Baeuerle, 
1994; Baeuerle, 1996; Grilli, 1993; Siebenlist, 1994). The NFκB/Rel family prototype is 
a heterodimer of a p50 (NF-κB1) and a p65 (RelA) subunit.  In unstimulated cells, the 
p50/p65 (NFκB) complex is sequestered in the cytoplasm by noncovalent association 
with IκB proteins including IκBα, IκBβ and p105 (Beg, 1993). These IκB molecules 
mask the nuclear localization signal (NLS) and thus prevent the translocation of NFκB to  
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the nucleus (Beg, 1992; Baldwin, 1996). In response to various stimuli, IκB molecules 
can be ubiquitinated, phosphorylated and then degraded by the ubiquitin-proteasome 
pathway releasing the NFκB/Rel complexes to the nucleus (Chen, 1995; Finco, 1995).  
Activation of NFκB by TNFα, mainly involves phosphorylation and degradation of IκBα 
and subsequent release and nuclear translocation of NFκB (Chen, 1995; Brockman, 1995; 
Brown, 1995). In addition to various kinases, reactive oxygen species (ROS) have also 
been implicated as upstream regulators of IκBα phosphorylation as well as second 
messengers in TNFα signaling leading to NFκB activation (Schreck, 1991; Baeuerle, 
1996). 
The degree of viral replication during the latency period can significantly alter the 
onset and progression of the disease (Embretson, 1993; Pantaleo, 1991; Mellors, 1996; 
O'Brien, 1996). Hence, cofactors that can amplify the TNFα induced activation of HIV-1 
expression in cells containing integrated provirus may have major clinical implications.  
Ability of TNFα to induce HIV-1 expression is amplified by internal host cellular factors, 
including other cytokines (Poli, 1990; Chun, 1998; Chowdhury, 1993; Bressler, 1993).  
Similarly, there are several external stimuli, including microbial pathogens and 
substances of abuse that can affect activation of HIV-1 both individually and in 
combination with TNFα (Harrison, 1997; Bernier, 1998; Bernier, 1998a; Peterson, 1992; 
Peterson, 1994; Chao, 1994). Among the different substances of abuse, alcohol is 
considered an important risk factor/cofactor (Molgaard, 1988; Hulse, 1993; Avins, 1994; 
Balla, 1994; Mahler, 1994; Zenilman, 1994; Gwati, 1995). 
Ethanol has been shown to cause impairment of neutrophil as well as T cell- 
dependent immune functions (Stoltz, 1999; Waltenbaugh, 1998; Brodie, 1994). In 
addition to its immunosuppressive effects ethanol may also contribute to the 
immunopathogenic mechanisms of HIV-1 infection by increasing viral replication 
(Bagasra, 1993; Bagasra, 1996). Data obtained from clinical as well as experimental 
studies have established an association with ethanol consumption and acceleration of 
HIV-1 disease progression (Balla, 1994; Fong, 1994; Wang, 1997). Hence, it is relevant 
to determine whether ethanol directly affects the expression of HIV-1 in cells carrying 
the provirus and/or modulates the inducibility of the virus in response to HIV-1 infection 
specific cytokines.  
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Since latently infected CD4+ T lymphocytes play a major role in the persistence 
of HIV-1 infection (Chun, 1995; Chun, 1997; Wong, 1997), we evaluated the role of 
ethanol as a possible cofactor in modulating TNFα signaling and subsequent HIV-1 
replication using the human CD4+ T cell line, Jurkat. Specifically, the effects of ethanol 
were determined by analyzing TNFα dependent NFκB activation and subsequent 
induction of HIV-1 LTR transcription. Oxidative stress and ROS, which play an 
important role in NFκB activation, are induced in cells and tissues that interact with 
ethanol and TNFα.  Hence, the involvement of ROS in the role of ethanol as a cofactor 
was also examined. Our findings indicate that ethanol, which by itself does not induce 
NFκB, potentiates TNFα induced NFκB nuclear translocation and HIV-1 LTR directed 
transcription in human CD4+ T cells.  Further, the data suggests that the mechanism(s) 
underlying the ethanol dependent potentiation of NFκB activation entail enhanced 
degradation of IκBα and formation of ROS. The synergistic effect of ethanol on TNFα 
inducible signaling and resulting HIV-1-LTR mediated transcription may explain a 
critical aspect of its role as a cofactor during HIV-1 pathogenesis. 
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Experimental Procedure 
 
Cell lines and plasmids 
 
The lymphoid T cell line, Jurkat E6-1 was supplied by the AIDS Research and 
Reference Reagent Program, NIH (Rockville, MD).  HIV-1 LTR-CAT was generously 
provided by Dr.C.Kunsch (Human Genome Sciences, Rockville, Maryland 20850). 
Jurkat E6-1 cells were cultured in RPMI 1640 medium (GIBCOBRL, Grand Island, NY) 
supplemented with 5% fetal bovine serum (GIBCOBRL), 100 units/ml penicillin and 
100µg/ml streptomycin (GIBCOBRL) at 37°C in a humidified atmosphere with 5% CO2. 
 
Cell treatments and extracts 
 
Cells were pretreated with different concentrations of ethanol, followed by 
treatment with TNF-α for different intervals of time. Nuclear and cytosolic extracts were 
prepared as described elsewhere60.  After incubation, cells were washed once with ice 
cold phosphate-buffered saline (PBS) and pelleted. The cell pellet was resuspended in 
250µl lysis buffer (10mM HEPES (pH 7.9), 1.5mM MgCl2, 10mM KCl, 0.5mM 
dithiothreitol (DTT), 0.5mM phenylmethylsulfonyl fluoride (PMSF), 1µg/ml leupeptin, 
1µg/ml pepstatin, 1µg/ml leucine thiol and 0.1% (v/v) Nonidet P-40) and incubated on 
ice for 30 min. Nuclei were collected by microcentrifugation (4000rpm, 4°C, 5min). The 
supernatant (cytosolic extract) was recovered and stored at -80°C.  Nuclei were 
resuspended in 200µl extraction buffer (20mM HEPES (pH 7.8), 25% Glycerol, 520mM 
NaCl, 1.5mM MgCl2, 0.1mM EDTA, 0.5mM PMSF, 0.5mM DTT, 0.2% Nonidet P-40, 
1µg/ml leupeptin, 1µg/ml pepstatin and 1µg/ml leucine thiol) and incubated on ice for 60 
min.  Nuclear debris was removed by microcentrifugation (15,000 rpm, 4°C, 20min). 
Supernatant (nuclear extract) was stored at -80°C in small aliquots until use. 
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Electrophoretic mobility shift assay (EMSA) 
 
The double-strand NFκB oligonucleotide probe containing the consensus NFκB 
binding site corresponding to the sequence 5 AGTTGAGGGGACTTTCCCAGGC- 3 
(Promega, Madison, WI) was labeled with [γ-32P] ATP (ICN, Costa Mesa, CA) by using 
T4 kinase (GIBCOBRL). Nuclear extracts were prepared as described above. Equal 
amounts of nuclear proteins (7µg), were incubated for 15 min on ice in reaction buffer 
[10mM Tris (pH7.5), 100mM NaCl, 1mM DTT, 1mM EDTA, 4%(v/v) glycerol, 80µg/ml 
sonicated salmon sperm DNA (GIBCOBRL)] followed by the addition of γ-32P-labeled 
ds NFκB probe (0.5 ng).  The reactions were incubated at room temperature for 20min 
and resolved on a 5% acrylamide/bisacrylamide (30:0.8%) nondenaturing gel in 0.5X 
TBE [50mM Tris (pH8.0), 45mM boric acid and 0.5mM EDTA]. Competition assays 
were performed by adding a 25-fold molar excess of either unlabeled ds NFκB probe or a 
ds mutant NFκB (mtNFκB) probe with a G to C substitution in the NFκB/Rel 
binding motif [5- AGTTGAGGCGACTTTCCCAGGC- 3 (Santa Cruz Biotechnology, 
Santa Cruz, CA)]. Supershift assays were performed by the addition of p65,  p50 and c-
rel polyclonal antibodies (Santa Cruz Biotechnology, Santa Cruz, CA), 15 min before the 
incubation with the γ-32P-labeled NFκB probe. Gels were dried and visualized by 
autoradiography.  Autoradiograms were scanned using Epson ES-1200C imaging system 
and the NFκB specific bands were analyzed using ImageQuant software (Molecular 
Dynamics, Sunnyvale, CA). 
 
Western blot analysis 
 
Cytosolic extracts were prepared as described above. 15µg of protein was 
separated by 10% SDS-polyacrylamide gel electrophoresis and electroblotted to 
nitrocellulose membrane in a buffer containing 30mM Tris, 200mM glycine and 20% 
methanol. The membranes were blocked by incubation in 1XTBS (10mM Tris HCl 
(PH8.0), 150mM NaCl) with 5% dried milk for 1h at room temperature and then 
incubated at 4°C overnight with IκB-α polyclonal antibody (Santa Cruz Biotechnology, 
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Santa Cruz, CA) in 5% milk/TBS at a dilution of 1:1000. After three 20-min washes with 
1XTBS, membranes were incubated with a secondary anti-rabbit IgG conjugated with 
horseradish peroxidase (Transduction Lab, Lexington, KY) at the dilution of 1:1333. The 
reaction was then visualized with the enhanced chemiluminescence detection system 
(ECL) as recommended by the manufacturer (Amersham International plc, 
Buckinghamshire, England). 
 
Transient Transfection 
 
Jurkat cells were transiently transfected with the pHIV-LTR-CAT plasmid by 
using Lipofectamine, as per the instructions supplied by the manufacturer (GIBCOBRL).  
Briefly, transient transfections were accomplished by using 8 µl of Lipofectamine reagent 
and 5 µg of plasmid DNA per ml per transfection reaction. Before adding to cells, the 
Lipofectamine-DNA complexes were allowed to form for 30 min at room temperature in 
serum-free medium.  Cells were prepared for transfection, by washing and resuspending 
in serum-free medium to obtain a final cell density of 2 x 106 cells/ml. Cells were 
incubated with the Lipofectamine-DNA complexes for 6 h, after which the serum-free 
medium was replaced with complete medium.  Cells were incubated further for 24 h 
before treatment with ethanol and/or TNFα. To minimize the variations in plasmid 
transfection efficiencies, transfected cells were pooled 24 h after transfection and were 
then seperated into various treatment groups.    
 
Chloramphnicol acetyl transferase (CAT) activity assay 
 
After treatment, the transiently transfected cells were harvested and washed once 
with 1 X PBS. Cell extracts were prepared by three cycles of freeze-thaw in 0.25M Tris 
(pH7.8). Protein concentrations were measured by the method of Bradford (Bio-Rad 
Laboratories, Richmond, CA) and equal amount of protein was analyzed from each 
sample. First, a 100µl reaction medium was prepared for each sample by mixing 0.4M 
Tris (pH 7.8), 0.5µCi 14C-chloramphenicol (35 to 55 mCi/mmol, ICN) and 1mM acetyl 
coenzyme A (Sigma).  Next, a 100µl protein/buffer mixture was prepared by adding 
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20µg of protein from each sample into CAT lysis buffer (250mM Tris-HCl (pH 7.8), 
0.5mM EDTA, 2µg/ml Aprotinin). After the addition of reaction medium to 
protein/buffer mixture, the total reaction mixture(200µl) was vortexed gently and 
incubated at 37°C for 1h. Samples were extracted with 1ml ethyl acetate, dried and 
spotted onto a thin layer chromatography (TLC) plate (Fisher). The plate was developed 
in a mixture of chloroform-methanol (95:5), dried and visualized by autoradiography. 
 
                                    25
  
 
Results 
 
Ethanol synergistically activates TNF-α inducible NFκB activation. 
 
TNFα is the major inflammatory cytokine that activates HIV-1-LTR, primarily 
through NFκB dependent transcriptional activation.  Hence, the effect of ethanol 
pretreatment on TNFα induced NFκB DNA binding activity was evaluated in Jurkat 
CD4+ T cells. Cells were treated at 370C with ethanol alone (25 mM, 2.5 h), TNFα alone 
(250 U/ml, 1.5 h) or pretreated with ethanol at different concentrations (10 to 100 mM, 1 
h) and subsequently treated with TNFα (250 U/ml, 1.5 h). Nuclear extracts from the 
treated cells were obtained and analyzed by EMSA using a NFκB specific probe. Little to 
no binding to the NFκB probe was observed in nuclear extracts from cells treated with 
ethanol alone and in the untreated cells (Fig. 3, lanes 1 and 2).  As expected, TNFα 
treatment induced substantial NFκB DNA binding (Fig. 3, lane 3).  Pretreatment with 
ethanol resulted in a significant enhancement of the TNFα inducible NFκB DNA binding 
activity.  Increase in the NFκB activation was seen at all the concentrations of ethanol 
with maximal increment observed at 25 mM. Although, prior exposure to ethanol 
consistently enhanced TNFα-inducible NFκB activation, some variation in the degree of 
enhancement was seen between experiments ranging from 2.0 to 4.0 fold. Importantly, 25 
mM ethanol concentration, which gave maximal enhancement of TNFα-inducible NFκB 
activation, represents blood alcohol levels corresponding to legal levels of intoxication 
achieved during social drinking (Werch, 1988). Hence all the subsequent experiments 
were performed with 25 mM ethanol. The specificity of the NFκB DNA binding activity  
was established by competition experiments on nuclear extracts obtained from TNFα 
treated cells. NFκB DNA binding activity was abrogated when 25-fold molar excess of 
unlabeled NFκB oligonucleotide probe (25X NFκB) was included in the DNA binding 
reaction mixture.  Additionally, competition with the 25-fold molar excess of mutant 
NFκB (25X mtNFκB) oligonucleotide probe with a G to C substitution in the 
NFκB/Rel DNA biding motif did not affect binding to the NFκB oligonucleotide probe. 
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Figure 3. Ethanol potentiates TNFα  inducible NFκB activation.
Jurkat cells were treated with TNFα (250 U/ml, 1.5 h) with or
without pretreatment with varying concentrations of ethanol for 1 h.
Nuclear extracts were prepared and analyzed by EMSA using NFκB
specific probe; arrows indicate the NFκB specific binding.
Competition assays were performed using the same nuclear extract
as in lane 3, by adding either 25-fold molar excess of unlabelled
NFκB probe or the mutant NFκB (mtNFκB) oligonucleotide probe.
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Identification of ΤΝFα induced NFκB complexes affected by ethanol. 
 
NFκB/Rel transcription factors are homo- or heterodimeric complexes that consist 
of various combinations of Rel subunits. To identify the subunits in the TNFα inducible 
NFκB complexes that are affected by ethanol, antibody supershift experiments were 
performed.  Nuclear extracts were obtained from cells treated with TNFα alone (250 
U/ml, 1.5 h) and cells that were pretreated with ethanol (25 mM, 1 h) followed by TNFα 
treatment (250 U/ml, 1.5 h).  In both treatments, the p65-specific antibody completely 
shifted complex C1 and the p50-specific antibody primarily shifted complex C2 and 
reduced the extent of binding of complex C1 (Fig 4; lanes2, 3, 5 and 6).  Since c-Rel is a 
component of activated NFκB in some cells, activated NFκB complexes were also tested 
for the presence of c-Rel.  The c-Rel specific antibodies had no effect on either complex, 
which shows that c-Rel does not participate in this NFκB activation process (Fig 4; lanes 
1 and 4). Data obtained with p50- and p65-specific antibodies indicates that the 
NFκB/Rel complexes induced by TNFα and enhanced by ethanol are the p50/p65 
heterodimer (C1) and p50/p50 homodimer (C2). 
 
Potentiation of TNFα inducible NFκB by ethanol involves enhanced IκBα 
proteolysis. 
 
 Under unstimulated conditions cytoplasmic inhibitory proteins collectively 
referred to as ΙκB bind to NFκB, and sequester it in the cytoplasm. A variety of stimuli 
can initiate signaling that leads to the degradation of specific ΙκB proteins, which results 
in the release and the nuclear translocation of  NFκB (Baldwin, 1996). In Jurkat T cells 
TNFα signaling that leads to NFκB activation predominantly involves  ΙκBα proteolysis 
(Chen, 1995; Finco, 1995; Brockman, 1995; Brown, 1995). In order to elucidate the 
mechanism underlying the enhancement of TNFα inducible NFκB DNA binding activity, 
the effect of ethanol on TNFα dependent  ΙκBα degradation was investigated. Western 
blot analysis was performed to examine the levels of  ΙκBα proteins in cytoplasmic 
extracts that were obtained from cells treated with either ethanol alone or TNFα (with or  
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TNF (250 U/ml, 1.5h)
Ethanol (25 µM, pre 1h)
p50
p65
c-Rel
  1       2        3        4        5        6      7       8
   +       +       +       +        +        +      +      +
   -        -         -       +        +        +      +       -
   -        -         +      -          -        +       -       -
   -        +        -       -         +        -        -       -
  +        -         -       +         -        -        -       -
C1
C2
S
Figure 4. Identification of TNFα inducedNFκB complexes affected by ethanol. Jurkat
cells were pretreated with ethanol (25mM, 1 h) followed by the treatment with TNFα
(250U/ml, 1.5 h). Nuclear extracts were prepared and analyzed by EMSA with NFκB
specific probe. Supershift assay was performed by using polyclonal antibodies specific
for p65 and/or p50.  C1 and C2 denote the various dimers of  NFκB and NS indicates
non-specific binding.  S denotes the complexes supershifted by either p65 or p50.
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without ethanol pretreatment [25 mM, 1 h]) for 15, 30, 60 and 90 min (Fig 5). Ethanol by 
itself was unable to cause ΙκBα degradation (lanes 2, 5, 8 and 11), which concurs with its 
inability to activate NFκB.  As expected,  ΙκBα degradation was observed at 15, and 30 
min in cells treated with TNFα (lanes 3 and 6).  Pretreatment with ethanol and the 
subsequent exposure to TNFα caused a greater loss of ΙκBα protein than did exposure to 
TNFα alone (compare lanes 3 and 4; 6 and 7).  Following degradation, ΙκBα resynthesis 
was initiated at 60 min (lanes 9 and 10) and reached at, or greater than, basal levels in 90 
min in both treatment arms (lanes 12 and 13).  In summary, this data suggests that prior  
exposure to ethanol modulates the TNFα signaling causing enhanced  ΙκBα proteolysis 
and subsequent release and translocation of NFκB into the nucleus.   
 
PDTC Inhibits Potentiation of TNFα Induced NFκB by Ethanol 
. 
Since NFκB activation, is known to be affected by redox processes, we further 
examined the role of oxidative stress and ROS in the effect of ethanol on TNFα mediated 
NFκB activation. Ethanol consumption causes elevation in TNFα and induces oxidative 
stress in adult tissues and is associated with subsequent ethanol related damage (McClain, 
1999; Bondy, 1992); additionally, exposure to ethanol, both in vivo and in vitro, results in 
the production of reactive oxygen species (ROS) (Bondy, 1992; Hill, 1998). PDTC is 
known to inhibit the formation of ROS and NFκB activation by certain stimuli in a cell 
type-specific manner (Schreck, 1992) and hence its effect on NFκB enhancement by 
ethanol was investigated. PDTC pretreatment (100 µM, 1 h), markedly suppressed NFκB 
activation in response to ethanol and TNFα (Fig 6). The data indicates that reactive 
oxygen intermediates are probably involved in the ethanol enhancement of TNFα 
inducible NFκB activation.  
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                                                               *                                               *
Lane Number            1               2              3              4               5              6              7
Time (min)                 0              15            15            15             30            30           30
Ethanol  25mM          -               +              -              +               +              -              +
TNFα 250 U/ml          -               -              +              +               -              +              +
LaneNumber              8              9            10             11            12            13
Time (min)                60           60            60             90            90            90
Ethanol 25mM           +              -              +              +              -              +
TNFα 250 U/ml          -              +              +              -              +              +
IκBα
IκBα
Figure 5. Ethanol enhances TNFα dependent IκBα proteolysis. Jurkat cells were treated
with ethanol alone, TNFα alone, and a one hour ethanol pretreatment followed by
TNFα (the treatments and times are indicated). After treatment, cytoplasmic extracts
were prepared and western blot analysis was performed using a polyclonal anti-
IκBα antibody. The asterisks highlight the synergistic effect of ethanol+TNFα on
IκBα degradation.
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Lane Number              1      2     3      4
TNFα  (250 U/ml)       +      +     +      -
Ethanol (25 mM)         -      +     +      -
PDTC   (100 µM)         -      -      +     +
Figure 6. PDTC inhibits NFκB activation effected by ethanol and TNFα.  Jurkat cells
were pretreated with 100 µΜ PDTC for 1 h and then treated with ethanol for 1h followed
by TNFα for 1.5 h.  Nuclear extracts prepared from these cells were examined for NFκB
activation by EMSA.
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Protein synthesis is not required for the potentiation of TNFα inducible NFκB by 
ethanol. 
 
Experiments were performed to exclude the possibility that ethanol enhanced 
TNFα inducible NFκB activation requires increased TNFα receptor synthesis and that 
the signal transduction molecules that are required for this process are pre-formed in 
cells.  Jurkat T cells were pretreated with the protein synthesis inhibitor cycloheximide 
(CHX) and then treated with ethanol and TNFα or TNFα alone.  Fig. 7 demonstrates that 
CHX had no effect on the potentiating effect of ethanol on NFκB activation. 
Additionally, the possibility of increased density of the TNFα receptors contributing to 
enhanced NFκB activation was addressed by flow cytometry analysis using a TNFα 
fluorokine (R&D System). After a 24 h exposure of the cells to ethanol pretreatment and 
TNFα, or TNFα alone, no significant changes in the cell surface receptor density were 
observed (data not shown).  Thus, the potentiation of the TNFα inducible NFκB appears 
to take place in the absence of protein synthesis and apparently does not require the 
induction of TNFα receptor expression.  
 
Ethanol enhances TNFα inducible HIV-1 LTR directed transcription. 
 
TNFα induces transcriptional activation of the HIV-1 LTR in cells containing 
integrated provirus, and it is associated with the induction of NFκB binding to the κB-
sites in the LTR (Duh, 1989). The observed ethanol mediated potentiation of the TNFα 
inducible NFκB DNA binding activity suggested a transcriptional mechanism by which 
ethanol may contribute to the enhancement of TNFα inducible HIV-1 expression. In 
order, to further elucidate the possible role of ethanol as a cofactor, its effect on TNFα 
inducible HIV-1 LTR promoter activity was examined in Jurkat T cells transiently 
transfected with the full length HIV-1 LTR CAT reporter construct. Ethanol treatment 
alone had no effect on the HIV-1 LTR expression, while predictably TNFα treatment  
stimulated LTR-mediated CAT expression (Fig. 8).  Importantly, pretreatment with 
ethanol led to a significant additional increase in TNFα inducible CAT activity as 
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Lane Number            1    2    3     4      5     6
TNFα (250 U/ml)      -    +    +      -      +     -
Ethanol (mM)           -    25  10    25     -     -
CHX (10 µg/ml)        -    +     +     +     +      -
Figure 7. Cycloheximide (CHX) does not inhibit the potentiating effect of ethanol on
TNFα inducible NFκB activation. Jurkat cells were pretreated with CHX (10 µg/ml) for
1 h and then treated with TNFα alone or ethanol for 1 h followed by TNFα for 1.5 h.
After treatment, nuclear extracts were prepared and analyzed by EMSA using a NFκB
specific probe. Arrows represent NFκB complexes.
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Figure 8. Ethanol pretreatment potentiates TNFα inducible HIV-1 LTR mediated
transcription.  Jurkat cells transiently transfected with pHIV-1 LTR CAT were treated
with ethanol (25 mM) and TNFα (250U/ml) alone or pretreated with 25 mM ethanol for
1 h followed by TNFα (250U/ml) for 24 h.  After 24 h treatments cell extracts were
prepared and analyzed for CAT activity.  The data shown represent the mean ± S.D. of
three independent experiments performed in triplicates.
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compared to cells treated with TNFα alone.  The observed effect of ethanol on HIV-1 
LTR CAT expression is in concordance with its ability to potentiate TNFα inducible 
NFκB activation.  Taken together these data suggest that ethanol at clinically relevant 
concentrations has the potential to enhance TNFα dependent HIV-1 replication in CD4+ 
T lymphocytes. 
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Discussion 
 
HIV-1 infection is characterized by a long period of latency during which a 
detectable reservoir of latently infected CD4+ T cells persist in HIV-1 infected 
individuals (Chun, 1995; Chun, 1997; Wong, 1997). Since these latently infected cells 
have the potential to be induced to produce the virus, internal and external stimuli that 
affect the activation of HIV-1 replication in these cells can significantly alter the onset 
and progression, of this disease.  Thus, an important aspect of HIV-1 pathogenesis is the 
possible interaction of external and internal stimuli that may lead to an increase in viral 
replication.   
Among several external stimuli that are implicated in HIV-1 infection and AIDS, 
alcohol consumption is recognized as an important risk factor (Molgaard, 1988; Hulse, 
1993; Zenilman, 1994). Several neurological, physiological and immunological 
abnormalities observed in HIV-1 infected patients are also found in chronic alcoholics 
(Tyor, 1999), which have led to the postulate that alcohol consumption can alter the 
progression of HIV-1 infection. Evidence from the HIV-1 infected cohort studies on the 
role of alcohol as a cofactor in HIV-1 disease progression is mixed and subject to various 
interpretations (Tyor, 1999; Cook, 1996).  It is important to note that these studies have a 
number of potentially confounding variables that hamper interpretation (for e.g. pre-
infection disorders, licit and illicit drug usage, rates and quantities of alcohol consumed, 
duration since HIV-seroconversion, absence of appropriate matched controls etc.) (Tyor, 
1999; Westerberg, 1992; Fein, 1998) leading to inadequate assessment. Evidence 
indicating the clinical association of alcohol use with the progression of HIV-1 disease, 
albeit limited, comes from studies evaluating (i) the effect of alcohol on progression of 
the neurological effects of HIV-1 infection which show that alcohol abuse exacerbated 
the neuropathological and CNS abnormalities of the HIV-1 infection (Tyor, 1999; Cook, 
1996; Fein, 1998; Deicken, 1991; Meyerhoff, 1995) and (ii) the adverse effect of alcohol 
on HIV-1 infection induced immunosuppression which show that alcohol withdrawal 
markedly improved the CD4+ cell count in HIV-1 infected alcoholic patients (Pol, 1996). 
Animal studies which examine the immunomodulatory effects of ethanol using the 
murine AIDS model (infection with LP-BM5 retrovirus), as well as the transgenic mouse 
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model (expressing the HIV-1 tat protein) have yielded results that are consistent with the 
hypothesis that ethanol exposure may enhance the progression of HIV-1 infection (Wang, 
1997; Wang, 1995; Prakash, 1998). Adverse effects of alcohol on HIV-1 disease 
progression are further supported by in vitro studies showing that (i) peripheral blood 
mononuclear cells (PBMCs) obtained from alcohol consuming subjects exhibit increased 
susceptibility to HIV-1, significantly increased HIV-1 replication and decreased ability of 
lymphocytes to produce interleukin-2 (IL-2) and soluble immune response suppressor 
activity upon activation, as compared to controls (Bagasra, 1993; Bagasra, 1996), (ii) 
CD4+ cell line, CEM, when exposed to alcohol in vitro and infected with HIV-1, supports 
significantly greater HIV-1 replication (Saravolatz, 1990) and (iii) exposure of 
lymphocytes from AIDS patients to low levels of alcohol (0.1%) significantly reduces 
their HIV-1 specific proliferative responses induced by the env (HIV-1 gp41 envelope) 
and gag (HIV-1 core) proteins (Nair, 1994). All these studies suggest a role for alcohol as 
a cofactor in HIV-1 pathogenesis. However, the effect of alcohol on cellular mechanisms 
relevant to HIV-1 disease progression remains undetermined. Among the internal stimuli 
critical for HIV-1 pathogenesis TNFα plays a central role in regulating HIV-1 replication 
(Folks, 1989; Michihiko, 1989; Matsuyama, 1991; Mellors, 1991) and elevated TNFα 
levels correlate with several AIDS associated pathophysiological changes (Tyor, 1999). 
Hence, to determine the molecular basis, if any for the proposed, of alcohol in HIV-1 
disease progression, its interaction with TNFα was assessed in the present work.   
Since latently infected CD4+ T cells are the critical source for reactivating HIV-1 
viral replication, where the transition from latency to active replication is primarily 
controlled by TNFα-inducible NFκB (Folks, 1989; Duh, 1989; Wu, 1995; Gollapudi, 
1998; Traber, 1999), we investigated the role of ethanol in the induction of HIV-1 
replication in these cells. We used HIV-1 LTR CAT reporter construct to transiently 
transfect the human CD4+ T cell line (Jurkat E6-1) to determine if ethanol, by itself or in 
collaboration with TNFα, affects the signaling involved in HIV-1 transcriptional 
activation.  The concentrations of ethanol used in this study reflect the blood alcohol 
levels that can be achieved during human alcohol consumption (Werch, 1988). 
NFκB plays a critical role in the induction of latent HIV-1 virus, and in the 
TNFα−mediated enhancement of virus production (Vicenzi, 1994; Wu, 1995; Gollapudi, 
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1998; Traber, 1999). Hence, we examined the effect of ethanol alone and its effect on 
TNFα induced NFκB activation.  The data obtained clearly shows that ethanol can 
strongly potentiate TNFα induced NFκB nuclear translocation (Fig. 3).  Importantly, 
ethanol by itself was unable to stimulate NFκB activation, which suggests that the 
synergy observed between ethanol and TNFα is fundamentally different from other T cell 
costimulatory systems where each stimulus independently activates NFκB (Harhaj, 
1996). Although, ethanol did not have any effect on NFκB activation in T cells it has 
been shown to affect NFκB activation in monocytes. In vitro exposure of human 
monocytes to 25 mM ethanol increased NFκB DNA-binding activity with a preferential 
induction of the transcriptionally inactive, p50/p50 NFκB/Rel homodimer with no 
induction of the p65/p50 heterodimer (Mandrekar, 1997). Taken together these 
observations suggest that ethanol affects NFκB activation in a cell-type specific manner.  
The mechanism by which TNFα mediates its effects on NFκB nuclear 
translocation is predominantly regulated by the targeted phosphorylation and subsequent 
degradation of IκBα. Data obtained on the effect of ethanol on TNFα induced IκBα 
proteolysis, and NFκB nuclear translocation, shows that a major component of the 
potentiation of the NFκB activation is enhanced degradation of IκBα (Fig 5). To further 
address the possible mechanisms involved in the effect of ethanol on NFκB activation, 
we considered the role of ROS. Generation of ROS has been implicated in the 
mechanism of NFκB activation in response to diverse stimuli including TNFα  (Baeuerle, 
1994). In this regard ROS appear to serve as messengers mediating directly or indirectly 
the release of the inhibitory subunit IκB from NF-kappa B (Schreck, 1991; Schreck, 
1992). Our results with PDTC, an antioxidant which is both a metal chelator and a radical 
scavenger, showed that enhancement of IκBα degradation and NFκB activation in 
ethanol and TNFα treated cells was PDTC-sensitive (Fig. 6), thus suggesting an 
important role for ROS in this mechanism. 
Agents that stimulate NFκB nuclear translocation induce the phosphorylation of 
IκBα on serine 32 and 36, which leads to the ubiquitination and the subsequent 
proteasome-dependent degradation. Recent studies show that TNFα induced IκBα 
degradation involves the activation of a kinase cascade. The distinct regulatory 
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components of this TNFα inducible cascade include the NFκB inducing kinase (NIK) 
that activates a high molecular mass (500-900 kDa) IκB kinase complex (IKK), which is 
comprised of two functional subunits IKKα and IKKβ that phosphorylate both serine 32 
and 36 in IκBα (Lee, 1997; Regnier, 1997). One or more of the multiple regulatory 
components involved in the TNFα  induced IκBα degradation and subsequent NFκB 
activation can be affected by ethanol. Hence, it will be our next step to investigate the 
role of ethanol and ROS in enhancing the TNFα induced catalytic activity of IKKα and 
IKKβ subunits. 
When the effect of CHX on ethanol mediated enhancement of TNFα inducible 
NFκB activation was analyzed, NFκB levels were found to be unaltered (Fig. 7). These 
data suggest that this ethanol -TNFα synergy is independent of protein synthesis, and the 
signal transduction molecules required, are not induced but pre-exist in these cells. The 
data also showed that this ethanol effect does not require TNFα receptor synthesis.  
These observations suggest that ethanol modulates the TNFα induced signal transduction 
pathways resulting in the enhancement of NFκB activation.  
To further verify, that ethanol can function as a cofactor in the pathogenesis of 
HIV-1 infection, we determined whether increased NFκB binding activity corresponded 
with an increase in NFκB-dependent HIV-1 LTR transcriptional activation. Consistent 
with its inability to activate NFκB, ethanol alone did not induce HIV-1 LTR activity.  
However, ethanol enhanced TNFα induced HIV-1 LTR transcriptional activity (Fig 8), 
commensurate with its ability to potentiate TNFα induced NFκB nuclear translocation.  
Additionally, the fact that PDTC has been shown to have an inhibitory effect on NFκB 
and HIV-1 LTR activation (Schreck, 1992), further substantiated the importance of 
NFκB in this process. These data suggest that clinically relevant concentrations of 
ethanol can increase the TNFα inducible HIV-1 LTR activity via a NFκB dependant 
signaling pathway.  
In summary, our data showed that the in vitro exposure of CD4+ T cells to 
ethanol, can enhance TNFα mediated NFκB activation and subsequent induction of HIV-
1 LTR transcriptional activity. Additionally, the data also indicated that the effect of 
ethanol on TNFα signaling involves ROS generation and enhanced degradation of IκBα. 
                                    40
  
 
Resting CD4+ T cells harboring latent HIV-1 provirus, reside in lymphoid tissue where 
endogenous cytokine secretion in response to antigenic stimuli is routinely encountered 
(Fauci, 1993; Pantaleo, 1991); they also traffic continuously throughout the body (Chun, 
1997). This offers extensive opportunity for ethanol-TNFα interaction to occur in HIV-1 
infected individuals following ethanol consumption.  If such a scenario is encountered 
during the course of an HIV-1 infection, this interaction could either enhance the 
expression of NFκB-regulatable proinflammatory cytokines, including TNFα, and/or 
have a potentiating effect on the reactivation of HIV-1 replication in latently infected 
CD4+ T cells. Overall, the data provide a possible mechanistic explanation for the role of 
ethanol as a cofactor that can adversely affect the progression from a latency state to 
clinical expression of HIV-1 related disease. An understanding of the effects of ethanol 
on host cellular mechanisms involved in HIV-1 pathogenesis may elucidate the 
relationship between alcohol consumption and AIDS risks, and thus allow the 
development of better prevention and intervention strategies. 
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Chapter Three 
 
Mechanism of Ceramide Induced CD4+ T cell Apoptosis 
 
Introduction 
 
The sphingomyelin pathway is a ubiquitous, evolutionary conserved signaling 
system. Most, if not all, mammalian cells appear capable of signaling through the 
sphingomyelin pathway. Sphingomyelin is a phospholipid preferentially concentrated in 
the plasma membrane of mammalian cells. The catabolic pathway for sphingomyelin is 
via the action of sphingomyelin-specific forms of phospholipase C (PLC), called 
sphingomyelinases (SMase), yielding ceramide and phosphorylcholine (Fig. 9). 
Ceramide generation in mammalian cells primarily occurs via receptor-mediated 
hydrolysis of sphingomyelin by the action of a neutral or acidic sphingomyelinase. Thus 
ceramide is defined as a central element in the metabolic pathway of sphingomyelin, 
serving both as a precursor and an intermediate product (Haimovitz-Friedman, 1997). 
Ceramide can also be generated by de novo synthesis involving the enzyme ceramide 
synthase. Several direct targets of creamide have been identified, including a ceramide-
activated protein kinase (CAPK) (Liu, 1994), a ceramide-activated protein phosphotase 
(CAPP) (Dobrowsky, 1992) and the protein kinase Cζ isoform (Lozano, 1994). In 
addition, ceramide interacts with several signaling systems, including the mitogen-
activated protein kinase (MAPK), c-Jun kinase (JNK), caspase and mitochondrial 
signaling system. In the following, details are given about the interaction between 
ceramide and each of the signaling pathways just mentioned. 
 
CAPK 
 
CAPK is stimulated by TNF-α and activated the MAPK pathway via 
phosphorylation of c-Raf-1 (Yao, 1995). Recently, it is concluded identical to the kinase 
suppressor of Ras (KSR) (Zhang, 1997). It is defined as a 97 kDa membrane-associated,  
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Figure 9. Sphingomyelin Metabolism
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proline-directed protein kinase. Treatment of cells with TNF-α or synthetic ceramide  
analogue enhanced KSR autophosphorylation, and increased its ability to phosphorylate 
and activate Raf-1 on Thr269. 
 
PKCζ 
 
PKCζ is an atypical PKC isoform which is insensitive to Diacylglycerol(DAG) and 
phorbol esters, but responsive to ceramide. Treatment of U937 cells or NIH3T3 
fibroblasts with TNF-α, SMase or ceramide analogue increased PKCζ phosphorylation 
and activity. PKCζ may play a role in TNF-induced activation of nuclear factor-κB (NF-
κB) in some cell types. The recent demonstration that PKCζ moves to the nucleus in 
response to ceramide elevation suggests that it may regulate the transcriptional events 
during ceramide signaling (Bertolaso, 1998). 
 
CAPP 
 
CAPP belongs to the protein phosphatase 2A family of serine/threonine 
phosphatases (Dobrowsky, 1993; Dobrowsky, 1993a; Law, 1995). These phosphatases 
exist as heterotrimers in which subunits A and B are regulatory and subunit C is catalytic. 
The B subunit is required for activation by ceramide. CAPP mediates an antiproliferative 
response to ceramide, arresting cells at the G1 phase of the cell cycle. It has been 
speculated that CAPP plays a role in down-regulation of c-myc expression in mammalian 
cells (Wolff, 1994). Also, some studies suggest CAPP may act as an antagonistic signal, 
inhibiting ceramide-mediated apoptosis by reversing effects on JNK. 
 
Ceramide and MAPK 
 
The MAPK pathway, also called ERK pathway, usually mediates growth and 
inflammatory signals (Fanger, 1997). Ceramide was shown to regulate the MAPK 
pathway in different cell types. In cos-7 cells, synthetic ceramide analogues and 
exogenous SMase mimicked the effect of TNF-α via successive activation events 
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involving KSR/CAPK, c-Raf-1, MEK and MAPK (Yao, 1995). Ceramide also mimicked 
TNF-α-induced activation of c-raf-1, MEK and MAPK in human vein endothelial cells, 
leading to a pro-inflammatory response (Modur, 1996). In T cells, stimulation of CD28 
engages the SMase signaling system for activation of the MAPK cascade, which is 
involved in proliferation (Boucher, 1995; Chan, 1995). 
 
Ceramide and JNKs 
 
The ERK cascade has been shown to communicate growth factor- and phorbol 
ester-induced proliferative signals. Recently, stress-activated protein kinase (SAPK), also 
known as c-Jun kinase (JNK) and p38 cascade has been defined. These cascades, 
activated by environmental stresses such as inflammatory cytokines, ATP depletion, heat 
and osmotic shock, ionizing and UV irradiation, and endotoxin have been shown to 
transmit growth arrest, differentiation, or apoptotic signals (Kyriakis, 1994; Kyriakis, 
1994; Cano, 1995). 
Recent evidence links ceramide-induced apoptosis to the SAPK/JNK protein kinase 
cascade in a variety of cell types. It has been reported that ionizing radiation, ultra-violet 
C radiation, H2O2, heat shock and TNF-α induce ceramide generation within seconds in 
primary cultures of bovine endothelial cells and U937 monoblastic leukemia cells, prior 
to activating the SAPK/JNK cascade (Verheij, 1996). Disruption of signaling down the 
SAPK/JNK cascade but not the ERK cascade, by overexpression of dominant negative 
mutants, abrogated TNF-, stress- and ceramide- induced apoptosis. These studies showed 
that the SAPK/JNK cascade was a downstream effector system for ceramide induced 
apoptosis. In contrast, ceramide and stress result in little or no change in ERK pathway 
activation in cells undergoing apoptosis (Pyne, 1996; Westwick, 1995). In fact, ERK 
cascade has been demonstrated to be anti-apoptotic. The inactivation of the ERK cascade 
was required in addition to the activation of the SAPK/JNK and p38 cascade for 
apoptosis to proceed in some cell types (Xia, 1995). This suggests that a balance between 
SAPK/JNK and ERK may be critical in affecting the apoptotic outcome. 
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Ceramide and Caspase 
 
Apoptosis in mammalian systems occurs by recruitment of a cascade of caspase 
proteases. Caspases, a family of cystein proteases with aspartate-specificity, are divided 
functionally into initiator caspase, such as caspases 2, caspase 8, caspase 9, caspase 10 
and effector caspases such as caspase 3 and caspase 7. Initiator caspase can couple to 
cytokine receptors of the TNF superfamily and link to effector caspase, which commit 
cells to the death program (Salvesen, 1997). It is well documented that ceramide 
functions proximal to effector caspases in mammalian system (Tepper, 1997; Dbaibo, 
1997; Waterhouse, 1996). Activation of effector caspases by ceramide is inhibited by 
Bcl-2 overexpression in numerous systems (Susin, 1996; Farschon, 1997; Martin, 1995). 
In the case of the TNF receptor, a protein termed TNFR-associated death domain 
(TRADD) binds via its death domain to the receptor and to another adaptor protein 
termed Fas-associated death domain (FADD) (Chinnaiyan, 1995; Chinnaiyan, 1996; Hsu, 
1995). CD95, however, does not require TRADD and binds FADD directly. In addition 
to its death domain, FADD contain a region termed as death effector domain (DED), 
another protein-protein interaction motif, which links to the DED of an ICE-like protease 
termed FLICE/caspase 8. It has been shown that formation of the ligand-dependent multi-
protein complex that links directly to an ICE protease is sufficient to initiate a protease 
cascade that effects apoptosis directly. However, in some cellular system the death 
domain adaptor protein mechanism may link to and utilize the sphingomyelin pathway 
for induction of apoptosis. Deletions and mutations of the death domain region of the 
TNF receptor (Wiegmann, 1994) and CD95 (Cifone, 1995), which abrogate induction of 
apoptosis, also block A-SMase activation. Further, Dixit and co-worker reported that 
overexpression of dominent negative FADD blocks ligand-induced ceramide generation 
(Chinnaiyan, 1996). 
 
Role of ceramide to radiation and drug induced cell death 
 
Recent investigations have implicated ceramide as a mediator of radiation-
induced apoptosis. Cells exposed to therapeutic doses of ionizing radiation were shown to 
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undergo rapid SM hydrolysis, ceramide generation and apoptosis (Michael , 1997; 
Haimovitz-Friedman , 1994; Chmura , 1997; Bruno , 1998). Ionizing and UV radiation 
have direct effects on the cell membrane (Cheng, 1996; Devary, 1992) and are capable of 
generating ceramide in isolated membrane (Haimovitz-Friedman , 1994), independent of 
the effect on nuclei. Further, lymphoblast from Niemann-Pick patients, who have an 
inherited deficiency of acid sphingomyelinase activity, fail to respond to ionizing 
radiation with ceramide generation and apoptosis. Both events are restorable by retroviral 
transfer of human A-SMase cDNA (Santana, 1996). Similarly, A-SMase knockout mice 
also expressed defects in radiation induced ceramide generation and apoptosis in vivo 
(Santana, 1996). 
Ceramide has been implicated in the apoptotic response to several 
chemotherapeutic drugs. Daunorubicin induced apoptosis is preceded by ceramide 
generation via activation of ceramide synthase (Bose, 1995). Alternatively, daunorubicin-
induced ceramide generation might result from neutral SMase activation (Jaffrezou, 
1996). 
 
Ceramide and ROS generation 
 
Cytokines such as IL-1β and TNF-α are known to induce the production of 
reaction oxygen species (ROS), a class of highly diffusible and ubiquitous molecules, 
which have been suggested to act as second messengers (Tiku, 1990; Lo, 1995; Devary, 
1991). ROS include species such as superoxide, hydrogen peroxide and hydroxyl 
radicals. Recent observations has shown that GSH (glutathione) depletion occurs 
upstream of N-SMase action and ceramide generation in TNF-α signaling in MCF-7 cells 
(Liu, 1997). Ceramide also has direct effect on isolated mitochondria, resulting in 
generation of ROS. The site of ceramide action was shown to be at respiratory complex 
III (Gudz, 1997; Garcia-Ruiz, 1997). 
Apoptosis is a genetically regulated, cellular suicide mechanism that plays a 
crucial role in development and defense of homeostasis (Cryns, 1998). The biochemical 
pathways of apoptosis can be initiated by a variety of physiological stimuli and 
environmental stresses. Inhibition of apoptosis is implicated in autoimmune disorders and 
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cancer, while increased apoptosis is believed to be associated with degenerative diseases 
(Fisher, 1994; Thompson, 1995).  
Ceramide has long been reported to play an important role as an intracellular 
mediator of apoptosis induced by inflammatory cytokines, environmental stresses and 
viral infections including TNFα, CD95/Fas/Apo-1, ionizing radiation, ultraviolet-C and 
HIV-1 infection (Jarvis, 1996; Hannun, 1996; Spiegel, 1996; Mathias, 1998). However, 
the exact mechanisms through which they mediate the pleiotropic activities of ceramide 
remain for the most part unknown. The sphingomyelin (SM) pathway is conserved from 
yeast to human. Lymphoblasts from Niemann-Pick patients, which have an inherited 
deficiency of acid sphingomyelinase activity, failed to respond to ionizing radiation with 
ceramide generation and subsequent induction of apoptosis. Both ceramide generation 
and apoptosis are restorable by retroviral transfer of human acid sphingomyelinase 
cDNA. Similarly, acid shingomyelinase knockout mice also expressed defects in 
radiation induced ceramide generation and apoptosis in vivo (Santana, 1996). Therefore, 
it appears that ceramide is an evolutionarily conserved signal, which is critical for 
apoptotic response. 
In the context of immune functions, ceramide mediated apoptosis is a major factor 
in the induction of immunosuppression. Cytokine-, stress- and pathogen-induced 
apoptosis leads to suppression of lymphoproliferative immune response and cell mediated 
immunity. Zinc is a crucial nutritional component required for the normal development 
and maintenance of normal immune functions. Clinical and experimental studies have 
shown that zinc deficiency leads to the impairment of cell mediated immunity. In regards 
to the effect of zinc on apoptosis and immunosuppression, it has been observed that (i) 
zinc deficiency can induce apoptosis in immune cells (McCabe, 1993; Treves, 1994; 
Martin, 1991) (ii) zinc supplementation can prevent apoptosis (Thomas, 1991; 
matsushita, 1996) and (iii) intracellular pool of chelatable zinc plays a critical role in the 
induction of late phase of apoptosis by affecting the activation or activity of calcium- and 
magnesium-dependent endonucleases (Cohen, 1984). 
The known antiapoptotic effect of zinc and the importance of ceramide as a 
critical mediator of apoptosis and immunosuppression led us to study the effect of zinc on 
the ceramide induced apoptosis in a human CD4+ T cell line (Jurkat E6-1) and peripheral 
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blood lymphocytes from healthy volunteers. Caspase 3 (CPP32/Yama/Apopain) is a well-
documentated effector caspase, which commits cells to the death program. Recent studies 
show that zinc is a potent inhibitor of caspase 3 activity in both a cell-free system 
consisting of purified PARP and recombinant caspase 3 (Perry, 1997) and 
geranylgeraniol (GGO) induced apoptosis in HL-60 cells (Aiuchi, 1998). Therefore, it 
raises the possibility that the prevention of apoptosis by zinc may be attributed to its 
effect on the early regulation phase of apoptotic signaling rather than the late 
execution phase. In the current study, we demonstrate that zinc at 100-1000µM 
completely inhibited ceramide induced DNA fragmentation and caspase 3 activity. The 
present report documents for the first time the antiapoptotic function of zinc against a 
critical mediator of inflammatory cytokine- and environmental stress-induced cell death 
and identifies its role in regulating the early or upstream apoptotic machinery.  
As I have mentioned earlier, ceramide could relay its apoptotic signal through 
SAPK/JNK cascade, resulting in the activation of transcription factors such as AP-1 and 
NFκB. The expression of Fas-ligand has been shown to be regulated by those 
transcription factors. Hence we further investigate the effect of ceramide on Fas ligand 
expression. We found that the induction of apoptosis in Jurkat CD4+ T lymphocytes by 
ceramide may involve CD95/Fas Ligand upregulation and this upregulation may be 
caspase 3 dependent.  
Considerable evidence suggests that apoptosis is the consequence of disrupting 
the balance of antiapoptotic and proapoptotic signaling within the cell (Yin, 1994; 
Knudson, 1997). Ceramide is primarily an inducer of apoptotic signals. Recently, the PI3-
kinase/Akt pathway has emerged to be a critical anti-apoptotic pathway for cell survival. 
So the role of Akt kinase on ceramide induced apoptosis is also evaluated. Interestingly 
we found that ceramide strongly induce inactivation and even degradation of Akt kinase 
and this effect seems to be caspase 3 independent.  
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Experimental Procedure 
 
Western Blot 
 
Total cell extracts were prepared and 15µg of protein from each sample was 
separated by 10% SDS-polyacrylamide gel electrophoresis and electroblotted to 
nitrocellulose membrane in a buffer containing 30mM Tris, 200mM glycine and 20% 
methanol. The membranes were blocked by incubation in 1XTBS (10mM Tris HCl 
(PH8.0), 150mM NaCl) with 5% dried milk for 1h at room temperature and then 
incubated at 4°C overnight with primary antibody in 5% milk/TBS. After three 20-min 
washes with 1XTBS, membranes were incubated with secondary antibody conjugated 
with horseradish peroxidase. The reaction was then visualized with the enhanced 
chemiluminescence detection system (ECL) as recommended by the manufacturer 
(Amersham International plc, Buckinghamshire, England). 
 
DNA fragmentation ELISA Assay 
 
DNA fragmentation was quantitated in the cytoplasmic extracts using the cell 
death ELISA kit manufactured by Boehringer Manheim (Indianopolis, IN) using a 
mixture of anti-histone-biotin labeled antibody and anti DNA peroxidase conjugated 
antibody as per the manufacturers instructions.  DNA fragmentation was quantified 
photometrically as a function of nucleosomes released, using ABTS (9,2,2-Azino-di[3-
ethylbenzthiazolin-sulfonate]) as the substrate. 
 
 Trypan Blue dye exclusion 
 
To measure viability, cells were stained with trypan blue dye and then the 
numbers of dead and living cells were counted by a previously described method 
(Mclowskey, 1998).   
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DEVDase like activity assay 
 
To measure DEVDase like activity, cytoplasmic extracts were prepared and 
analyzed using the CASPASE 3 Cellular Activity Assay Kit PLUS  (BIOMOL Research 
Laboratories, Inc. 5100 Campus Drive Plymouth Meeting, PA-19462).  
 
DNA Fragmentation Analysis by Gel Electrophoresis  
 
To measure DNA fragmentation qualitatively, cells were lysed and DNA isolated 
via a method that has been described earlier (42).  Briefly, the cells were solubilized in a 
lysis buffer (10mM Tris pH 8.0, 100mM NaCl, 25mM EDTA, 0.5% SDS and 400mg/ml 
Proteinase K and incubated overnight at 37°C.  The samples were then extracted three 
times with an equal volume of phenol: chloroform: isoamyl alcohol (25:24:1) followed 
by a chloroform extraction.  The DNA was precipitated in the presence of 0.3M NaOAc 
(pH 5.2) and 10mM MgCl2 with three volumes of EtOH.  The precipitated DNA was 
resuspended in dH20, treated with RNAse A (10 mg/ml) for one hour at 37°C, re-
extracted and precipitated.  The concentration of DNA was quantitated by UV 
absorbance at 260 nm. Ten micrograms of DNA were analyzed by gel electrophoresis on 
a 1. 6 % agarose gel, and visualized by staining with 0.4 µg/ml Ethidium Bromide. 
 
Akt-kinase activity assay 
 
Stimulated cells were collected and lysed in lysis buffer (PBS pH 7.4, 1% NP-40, 
200 µM sodium orthovanadate, 0.1 mg/ml phenylmethylsulfonyl fluoride (PMSF), 10 
µg/ml aprotinin, 10 µg/ml leupeptin, 4 µg/ml benzamidine, 50 mM potasium fluoride, 
1mM β-glycerophosphate, 5 mM sodium pyrophosphate, 1µM okadaic acid) and 
centrifuged at 15,000g for 10 min at 4 °C. Supernatants were incubated for 2 hr at 4 °C 
with 10-20 µg of goat anti-PKB antibody conjugated protein G-agarose. 
Immunoprecipitates were washed in lysis buffer and three times in assay buffer (20 mM 
MOPS pH 7, 25 mM β-glycerophosphate, 5 mM EDTA, 1 mM sodium orthovanadate, 1 
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mM dithiothreitol). The final agarose pellets were resuspended in assay buffer and 
incubated with Akt substrate in assay buffer. The reaction is started by adding 10 µ Ci 
[32P]-ATP diluted with 0.5 mM cold ATP and the samples were incubated for 15 min at 
37°C. Equal amount of supernatant was transferred to Pierce Phosphocellulose Unit and 
washed 3 times by Pierce binding buffer. The membrane portion of the Unit was counted. 
 
MTT assay 
 
Cell survival was measured using the MTT (3, (4,5-dimethylthiazol-2-yl) 2,5-
diphenyltetrazolium bromide) assay as described by Hansen et al. (113). Briefly, the cells 
were seeded onto 96-well culture plates at a density of 20,000 cells/100µl medium per 
well. After treatment of the cells, 25 µl of a 5 mg/ml stock solution of MTT was added to 
each well, and incubated at 37 °C for 2 hrs to allow cells to take up the dye and convert it 
to the formazan derivative. The formazan was solubilized by the addition of 100 µl of 
lysis buffer (20% SDS in 50 % DMF, pH 4.7), and optical density was measured after a 
24 hrs incubation at 37 °C using a Dyna Tec-700 plate reader. 
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Results 
 
Ceramide Induces Caspase 3 Activation and DNA Fragmentation 
 
Since ceramide is an important mediator of cytokine and stress induced apoptosis, 
we investigated the effect of exogenous cell-permeable short chain ceramide in Jurkat T 
cell line. Cells were exposed to increasing concentrations of C2 ceramide (1,10,30,50µM) 
for 5h at 37°C. Then, total chromosomal DNA was isolated and analyzed by agarose gel 
electrophoresis. Up to 10µM, C2 ceramide did not induce DNA fragmentation (Fig. 10, 
lane 2 and 3). However, ceramide at or greater than 30µM consistently and significantly 
induced DNA fragmentation in a dose-dependent pattern (Fig. 10, lane 4 and 5). The 
cytosolic caspase 3 (cpp32/YAMA/apopain) becomes activated in apoptosis in different 
cell types (Kyriakis, 1994; Kyriakis, 1995). Hence, we further analyzed the effect of 
ceramide on the induction of caspase 3 activity. The functional activity of caspase 3 was 
measured by its ability to hydrolyze a specific fluorogenic substrate, Ac-DEVD-AMC. 
Similar to the DNA fragmentation data, this experiment showed that C2 ceramide at or 
greater than 30µM dose-dependently induced caspase 3 activity in Jurkat cells (Fig. 11). 
The above results confirm that ceramide-induced apoptosis involves caspase 3 activation 
and subsequent DNA fragmentation. 
 
Zinc Inhibits Ceramide-Induced DNA Fragmentation 
 
To investigate the effect of zinc on ceramide-induced DNA fragmentation, cells 
were either treated with 30µM C2 ceramide alone or pretreated with different 
concentrations of zinc for 1h followed by the treatment of 30µM C2 ceramide for 5h. At 
the high pharmacological concentrations, namely 500 and 1000µM, zinc was able to 
completely block ceramide-induced DNA fragmentation (Fig. 12, Lane 2,3,4). At low 
pharmacological concentrations (50 and 100µM), zinc consistently blocked ceramide-
induced apoptosis at 100µM (Fig. 12, lane 6), but not at 50µM (Fig. 12, lane 5). Zinc by 
itself had no effect at all concentrations. These data suggest that pretreatment of zinc  
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Figure 10. Dose dependent ceramide-induced DNA fragmentation.
Jurkat cells were treated with increasing concentrations of short-
chain Ceramide for 5 hours. DNA fragmentation was detected by
agarose gel electrophoresis.
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Figure 11. Effect of ceramide on caspase 3 activity. Jurkat cells
were treated with increasing concentrations of short-chain
ceramide for 3hrs. The activity of functional caspase 3 was
detected by its ability to hydrolyze a specific substrate.
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from 100 to 1000µM can effectively protect Jurkat T cells from C2 ceramide-induced 
DNA fragmentation which is a biochemical hallmark of apoptosis. 
 
Zinc does not Block Ceramide-Induced Caspase 3 Processing 
 
Caspase 3 proteases are expressed in the intact cell as the form of 32-kDa 
zymogens. Exogenous C2 ceramide has been shown to induce the proteolytic cleavage of 
the 32-kD proform of the protease to two subunits of 20-kD and 12-kD respectively 
(Cano, 1995). The effect of zinc on caspase3 processing was examined by western blot 
analysis using an antibody specific to the 32-kD protein. C2 ceramide at 30µM was 
observed to induce significant caspase 3 activation, which resulted in a substantial loss of 
the 32-kD zymogen (Fig. 13, lane 2). Zinc at 100 and 250µM, which can effectively 
block ceramide-induced DNA fragmentation, had no effect on ceramide-induced caspase  
3 processing (Fig. 13, lane 3 and 4). Therefore, it suggests that the inhibition of ceramide-
induced DNA fragmentation by zinc is not due to the prevention of caspase 3 activation. 
 
Zinc Directly Inhibits Ceramide-Induced Caspase 3 Activity. 
 
Since zinc dose not block ceramide-induced caspase 3 processing, we further 
investigated its effect on caspase 3 function. Corresponding to the DNA fragmentation 
data, zinc at 50µM had minimal effect on ceramide-induced caspase 3 activity (Fig. 14, 
lane 3), but zinc at 100µM and higher can significantly inhibit activated caspase 3 
function (Fig. 14, Lane 4). Considering the fact that zinc can directly inhibit caspase 3 
activity in a cell-free system (Boucher, 1995), our results suggest that the antiapoptotic 
effect of zinc is due to its ability to inhibit directly the active caspase 3 function, but not 
caspase 3 activation. 
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Figure 13. Zinc has no effect on Ceramide-Induced Caspase 3 Processing.
Jurkat cells were treated with C2 ceramide for 5h with/without zin
pretreatment for 1h. Total cell lysate was evaluated by western blot using a
specific antibody to CPP32/caspase 3.
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Figure 14. Zinc inhibits ceramide induces caspase 3 activity.
Jurkat cells were pretreated with zinc followed by treatment
with short-chain ceramide for 3hrs. The activity of functional
caspase 3 was detected
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Zinc Protects Human Peripheral Blood Lymphocytes From Ceramide-Induced Cell 
Death 
 
To exclude the possibility that the antiapoptotic effect of zinc is cell-line specific 
and to further investigate its clinical relevance, the effect of zinc on ceramide-induced 
cell death was studied in human peripheral blood lymphocytes (PBLs) from healthy 
donors. Cells were pretreated with 100µM zinc, followed by the treatment of 30µM C2 
ceramide. Cell death was determined by the inability of dead cells to exclude trypan blue 
dye and DNA fragmentation was also quantitatively measured. Similar to the results from  
Jurkat cells, C2 ceramide at 30µM can significantly induce DNA fragmentation and cell 
death in PBLs, which were strongly attenuated by the pretreatment of zinc at 100µM 
(Fig. 15A, B). These data support the antiapoptotic effect of zinc on ceramide-induced 
apoptosis and also imply its potential value in clinical therapeutic intervention. 
 
Ceramide Induces Fas Ligand up-regulation 
 
Fas (APO-1, CD95) is a type I cell surface protein belonging to the tumor 
necrosis factor/nerve growth factor receptor family that transduces cell death signals upon 
binding to Fas ligand (FasL). Fas is expressed in a variety of cell types such as activated T 
cells and B cells, macrophages, and hepatocytes. FasL is a 40-kD type II membrane 
protein belonging to the tumor necrosis factor family of ligands. Binding of Fas ligand 
(FasL) or stimulation with agonistic antibodies leads to aggregation of the Fas receptor 
on the cell membrane and the recruitment of specific intracellular signaling molecules 
and further initiates cell apoptotic machinery. Since ceramide is also a strong inducer of 
apoptosis, in this study we investigated if there is any interaction or relation between 
ceramide and Fas/FasL system. Jurkat cells were treated with short-chain ceramide for 
3h. Cell lysate was prepared and evaluated by western blot. Fas ligand protein level was 
detected with an anti-CD95-specific antibody. From Fig. 16, we found that in untreated 
cells there is a base-line level of Fas ligand expression. Short-chain ceramide at 30µM 
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Figure 15. Zinc blocks ceramide induces DNA fragmentation in
human peripheral blood lymphocyte. PBLs from healthy donors
were exposed to C2 ceramide with/without zinc pretreatment.
(a) After the treatment of C2 for 5h, DNA fragmentation is detected
by ELISA using a anti-histone Ab. (b) Cell death is evaluated by
Trypan Blue exclusion 24h after ceramide treatment.
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strongly induced Fas ligand expression (Fig. 16, Lane 5), which correlates with the data 
of ceramide induced caspase 3 activation and DNA fragmentation. 
 
Inhibition of ceramide induced DNA fragmentation and Fas ligand upregulation by 
DEVD-cho. 
 
Recent studies have provided compelling evidence that a cascade of Asp-directed 
cysteine proteases, caspases, plays a pivotal role in the transduction of apoptotic signals. 
Among this group, caspase 3 is one of the most studied and is normally considered as a 
common executor in the effector phase of the death program induced by a variety of 
stimuli. Interestingly, several recent reports suggested that caspase 3 could also be 
involved as a regulator in the early or induction phase of apoptosis. In this study, we 
investigated the interaction of caspase 3 activation and FasL upregulation in the context 
of ceramide induced apoptosis in CD4+ Jurkat cells. To conduct this study, we used a 
peptide inhibitor, called Ac-DEVD-cho, which primarily inhibits caspase 3 activity. In 
Fig. 17, pretreatment of Jurkat cells with DEVD-cho completely protects cell from 
ceramide induced DNA fragmentation. Then we checked what happened on the protein 
level of FasL. Again, ceramide at 30µM strongly induced FasL expression (Fig. 18, Lane 
5). Noticeably, pretreatment of 100µM DEVD-cho for 1h significantly blocked ceramide 
induced CD95L upregulation (Fig. 18, Lane6). This result supported that ceramide 
induced FasL upregulation may be caspase 3 dependent. 
 
Inhibition of Protein Kinase B/Akt by ceramide 
 
Generation of the membrane sphoingolipid ceramide constitutes an important 
signaling event activated by cellular stresses. Ceramide is an important second messenger  
in relaying apoptotic signals. As we have shown above, ceramide was able to induce 
caspase 3 activaty and also potentiate the proapoptotic Fas/FasL pathway by upregulating 
the expression of CD95 ligand. On the other hand, ceramide may also augment the 
apoptotic effect by inactivation of anti-apoptotic pathways. Protein kinase B has recently  
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Figure 18. Ceramide-induced CD95L upregulationis partially blocked
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FasL is evaluated by western blot.
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emerged as a critical survival factor with its targets including Bad, caspase 9 and the 
Forkhead family of transcription factors. By knowing all the facts above, we are inspired 
to study the possible relationship between ceramide and PI3K/Akt pathway. First, we 
pretreated cells with PI3K-specific inhibitor LY294002, followed by the treatment of C2 
ceramide. We found that inhibition of PI3K by LY294002 sensitized Jurkat cells to C2 
ceramide induced cell death (Fig. 19). Next, we treated cells with C2 ceramide at 30µM 
and measured the Akt kinase activity in the cell lysate. The Akt kinase activity in 
ceramide treated cells was greatly reduced (Fig. 21, lane8, Page 101). This could be 
considered as a noval mechanism for ceramide to conduct its proapoptotic effect. It is not 
clear whether ceramide can directly inhibit Akt activity or do so through interacting with 
another molecule (i.e. PI3K). 
 
Inhibition of Akt by ceramide may be caspase 3 independent 
 
Since caspase 3 was involved in ceramide induced FasL upregulation in CD4+ 
Jurkat T lymphocytes, the next question we asked is whether caspase 3 has anything to do 
with ceramide induced Akt inactivation. Jurkat cells were treated with C2 ceramide with 
or without the pretreatment of the peptide inhibitor DEVD-cho. Then total cell lysate was 
prepared and evaluated by western blot using antibodies specifically recognizing 
phospho-Akt and unphosphorylated Akt. From Fig. 20, we can see that ceramide 
treatment completely wiped out phospho-Akt and DEVD-cho pretreatment was unable to 
block this effect. This result suggests that ceramide induced Akt kinase inactivation may 
take place in the early phase of apoptosis upsteam of caspase 3 activation.  
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Figure 19. LY sensitized Jurkat cells to C2 ceramide induced cell death.
Jurkat E6-1 cells were seeded on 96-well plate with the treatment of
increasing concentrations of C2 ceramide (0, 10, 20, 30µM) with the
presence of different concentrations of LY 294002 (0, 10, 15, 25, 50µM).
Cell viability was measured  by MTT assay.
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western blot.
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Figure 21. Ceramide, LY294002 and Wortmannin dose-
dependently attenuated the activity of Akt/PKB. Jurkat E6-1 cells
were treated with different concentrations of LY294002,
Wortmannin and C2 ceramide. Cells were harvested and prepared
for the measurement of Akt kinase activity.
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Discussion 
 
It is well known that the apoptosis program is constitutively expressed in most if 
not all cells. Apoptosis can be initiated by a variety of physiological and environmental 
stimuli, which are able to trigger one of several distinct apoptotic pathways (Adriana, 
1997). The specific signaling pathway activated depends on different cell types and 
especially the subcellular factors or targets the stimuli would specifically turned on. The 
different upstream signaling pathways seem to share or converge downstream to a 
common final execution mechanism to disposal the dying cells. Dr. Horvitz and co-
workers defined the Ced-3 gene of the nematode Caenorhabdtis elegans and its human 
analog, the IL-1β converting enzyme (ICE) family of proteases as the principle executors 
or effectors to carry out the disposal of the apoptotic cells (Yuan, 1993). The ICE/Ced-3 
proteases are synthesized as zymogens and are activated by either autocatalysis, cleavage 
by other ICE/Ced-3 proteases or the serine protease granzyme B. During apoptosis, 
ICE/Ced-3 proteases are responsible for the orderly progression of the disassembly of 
cellular organelles. Several targets of ICE/Ced-3 proteases have been identified. The 
nuclear enzyme, poly-ADP-ribose-polymerase (PARP), involves in DNA damage repair, 
and is cleaved by CPP32/Caspase3 (Lazebnik, 1994). Other targets of caspase 3 include 
topoisomerase, the U1-ribonuclearprotein, the nuclear protein lamin, the cytoplasmic 
protein kinase Cδ, and the membrane protein fodrin, to list a few (Fraser, 1996).  
Immense amount of work has been done to clarify mechanisms by which 
extracellular signals activate the ICE/Ced-3 proteases to conduct apoptosis. The apoptotic 
function of cytokine receptors, such as Fas/Apo-1/CD95 were reported to link with the 
ICE/Ced-3 effector caspase via a receptor-associated death domain adaptor protein 
system. While formation of the death domain adaptor protein complex seems to be 
independent of the sphingolipid secondary messanger ceramide, emerging data suggest 
that its ability to confer apoptosis is dependent on coordinated signaling via ceramide. 
Deletions of the death domain region of TNF receptor (Wiegmann, 1994) and CD95/Fas 
(Cifone, 1995), as well as overexpression of dominant negative FADD/MORT1 blocked 
ligand-induced ceramide generation and apoptosis. Further, another report suggested that 
treatment with ceramide analogs can bypass the antiapoptotic effect of dominant negative 
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FADD/MORT1 and restore apoptosis (Chinnaiyan, 1996). In the current study, we 
confirmed that cell-permeable short chain C2 ceramide is a strong inducer of caspase 3 
activity (Fig. 11) and subsequent DNA fragmentation (Fig. 10).  
The influence of Zn2+ on apoptosis is a well-known phenomenon. In both in vitro 
and in vivo studies, Zn2+ supplementation prevents apoptosis induced by a variety of 
agents (Thomas, 1991). Cells grown under the condition of Zn2+ deficiency will undergo 
spontaneous apoptosis (McCabe, 1993). Traditionally the inhibitory effect of Zn2+ on 
apoptosis is attributed to its inhibition of a Ca2+- and Mg2+- dependent endonuclease, 
which is responsible of selectively cutting nuclear DNA and causes DNA fragmentation. 
However, there has always been unsolved doubts about this. Concentrations of Zn2+ used 
for inhibition of the purified endonuclease were in millimolar range (Gaido, 1991), which 
seems unachievable physiologically. Since endonucleases function primarily during the 
execution rather than regulation phase of apoptosis, its inhibition may not be enough 
to rescue cell from apoptosis. Recent studies suggest that Zn2+ may interact with some 
other apoptotic factor, which is involved in the earlier stage of apototic machinery. In a 
cell-free system consisting of purified PARP as a substrate and an apoptotic extract or 
recombinant caspase 3 as the PARP protease, Zn2+ inhibited PARP proteolysis in the low 
micromolar range (Perry, 1997). This raises the possibility that caspase 3 could serve as a 
novel target for zinc in the inhibition of apoptosis. In this study, we evaluated the effect 
of zinc on ceramide induced apoptosis in CD4+ Jurkat T lymphocytes. From Fig. 12, we 
clearly showed that Zn2+ from 100 to 1000 µM completely blocked ceramide induced 
apoptosis. More importantly, the ceramide induced caspase 3 activity is also abrogated by 
zinc pretreatment (Fig. 14). The procaspase 3 can still be processed (Fig. 13), however 
the activity of functional caspase 3 is being blocked (Fig. 14). The direct mechanism by 
which Zn2+ inhibits caspase 3 still awaits further investigation. However, studies on the 
crystal structure of ICE family members suggested that His-237 and Cys-285 are 
involved in catalysis and conserved in all the caspase family members (Walker, 1994; 
Kamens, 1995). Therefore, it is very possible that Zn2+ could inhibit caspase 3 activity by 
interacting with one or both of the conserved sites.  
Caspase 3 has been classified mainly as an executor caspase. It is accurate in a 
way that it is the most important protease in dismantling subcellular organelles. However, 
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caspase 3 does have some other regulatory function in apoptotic signaling. As we showed 
here in Fig. 16, ceramide was able to upregulate the expression of a proapoptotic factor 
Fas ligand. This upregulation seems to be dependent on caspase 3 activity. Pretreatment 
of caspase 3 inhibitor DEVD-cho significantly attenuated this effect (Fig. 18). One 
important thing is that DEVD-cho can also interact with other caspases (i.e. caspase 7) to 
a lesser magnitude. Therefore we cannot rule out the possibility that other DEVDase may 
also participate in this effect. As mentioned before, Fas receptor ligation can induce 
endogenous ceramide accumulation and further activate caspase 3. So it seems to me that 
this upregulation of FasL by ceramide could be a positive feedback to amplify the 
apoptotic signaling cascade to help further carry out the death program.  
Apoptosis is not simply controlled or conveyed by only proapoptotic signaling 
pathways. It is more likely under tight regulation by both proapoptotic and anti-apoptotic 
factors. PI3K/Akt has emerged as an important anti-apoptotic pathway. As shown in the 
next chapter, inhibition of this pathway without further stimuli was enough to induce 
apoptosis in Jurkat cells. In Fig. 21 Lane 8, the activity of Akt kinase was greatly reduced 
by ceramide treatment. In western blot analysis, the amount of active form of Akt, 
phospho-akt, was also significantly decreased (Fig. 20) and DEVD-cho pretreatment 
cannot restore Akt level (Fig. 20). This result put Akt kinase upstream of caspase 3 
activation, which is expectable because caspase 9 and bad, a bcl-2 family member, are 
well-identified targets of Akt kinase. The exact mechanism of ceramide induced Akt 
inactivation is still unclear. Some studies suggest that ceramide can inhibit PI3K activity 
further leading to the inactivation of Akt kinase (Zundel, 1998), while others speculated 
that ceramide could activate a phosphatase to inactivate Akt by dephosphorylation (Zhou, 
1998).  
The role of sphingolipid ceramide in apoptosis has been the subject under intense 
investigation. Ceramide has been reported to play many important roles in cellular 
responses such as differentiation, proliferation or death (Hannun, 1996). Ceramide has 
been shown to affect almost every cell or tissue type examined, resulting in a wide range 
of effects in a cell-type specific manner. In HIV-infected individuals, lymphocyte 
apoptosis is considered as major cause for T cell depletion and disease progression. It has 
been reported that CD4+ and CD8+ T cell from HIV patients display large increase in 
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ceramide content and apoptosis as compared to normal people (Dimarzio, 1997; Cifone, 
1997). Alternatively, treatment of HIV-infected patients with L-carnitine, which reduced 
acid SMase activity, significantly reduced ceramide levels in peripheral blood cells and 
partially restored CD4 count. In the treatment of cancer, suppression of anti-apoptotic 
signals might increase the sensitivity of target tissues to radiation and chemotherapy. 
Inhibition of ceramide signaling may provide protection from endotoxic shock, and 
attenuate ceramide-mediated effects in ischaemia/reperfusion injury, in the development 
of atherosclerosis and in insulin-resistant diabetes. Better understanding of the 
mechanisms by which ceramide regulates physiological and pathological events may 
yield opportunities and potentials to therapeutic intervention. 
 
 
                                                                     73 
 
Chapter Four 
 
The Role PI3K/Akt Pathway in Oxidative Stress Induced Apoptosis 
 
Introduction 
 
Apoptosis is the main cause of CD4+ T-lymphocyte depletion in acquired immune 
deficiency syndrome (AIDS).  The tropism of human immunodeficiency virus (HIV) for 
CD4+ T cells and its cytopathic effect in vitro suggested that the pathogenesis of AIDS 
was strictly dependent on the direct virus-mediated destruction of CD4+ lymphocytes 
(Pantaleo, 1993). Also, the dynamic interaction between HIV replication and the 
destruction of CD4+ lymphocytes was further supported by the observation that when 
effective antiretroviral treatments was applied, levels of HIV replication declined sharply 
over a period of 1 to 2 weeks and the CD4+ lymphocyte count increased correspondingly 
(Ho, 1995; Wei, 1995; Piatak, 1993).  The above reports appear to suggest that the direct 
infection of the cells with subsequent cytotoxicity is the most obvious explanation for the 
loss of CD4+ T cells. However, there are a few unexplained points. Particularly, it has 
been shown that during the clinically latent period only a small amount of CD4+ cells are 
detectably infected with the virus (Ho, 1989; Bagasra, 1992). The proportion of those 
cells that actively express HIV virus seems insufficient to account for the continued 
decrease in total T cell numbers. There is evidence that many other mechanisms, in 
addition to the direct cytotoxicity effect of the virus, may play important roles in CD4+ 
cell depletion, for example indirect killing, stem cell infection or failure, autoimmunity, 
and superantigen effects (De Simone, 1996). Later it became apparent that the loss of 
CD4+ T cells in HIV infection is associated with incomplete lymphocyte activation. It 
paradoxically results not in cell proliferation, but rather in cell death by a process that is 
physiologically crucial for the proper development and homeostasis of many tissues, and 
is called apoptosis (Gougeon, 1993). The in vitro activation of mature T cells from 
asymptomatic HIV-infected individuals by polyclonal activator has been shown to induce 
apoptosis in both CD4+ and CD8+ cells (Ameisen, 1995; Ameisen, 1994). In addition,  
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specific cell death of CD4+ lymphocytes is observed upon activation of T cells by major 
histocompatibility complex class-II-dependent bacterial superantigens. Even in the 
absence of activating agents a high background amount of apoptosis occurs in cultured 
lymphocytes of HIV-infected patients (Ameisen, 1995; Ameisen, 1994). Early 
investigation of the pathologic mechanism underlying T-cell death in HIV-infected 
persons showed that crosslinking of the CD4 molecule by anti-CD4 antibodies or by the 
HIV-1 envelope protein can trigger apoptosis in human CD4+ T cells (Banda, 1992; 
Cohen, 1992; Oyaizu, 1993; Laurent-Crawford, 1991; Tian, 1993). Abnormal levels of 
lymphocyte apoptosis have been shown in HIV-infected patients, and this involves not 
only CD4+ cells but also CD8+ cells (Gougeon, 1993, Carbonari, 1994). Interestingly, 
both CD4+ and CD8+ cells from HIV-infected long-term survivors who remain clinically 
healthy and immunologically normal over an extended period of time, have a low 
propensity to undergo apoptosis with respect to intermediate or advanced progressors. 
These latter observations argue strongly in favor of the hypothesis that apoptotic 
mechanisms contribute to the pathogenesis and progression of HIV infection. However, 
the progression of HIV infection is markedly characterized by the progressive depletion 
of CD4+ cells, whereas CD8+ lymphocytes are preserved to a substantial level (Pantaleo, 
1993). A possible explanation could be that even though all lymphocyte subsets undergo 
progressive apoptosis, the renewal of CD4+ cells is selectively impaired in such a 
situation (Bonyadhi, 1993). The preservation of CD8+ cell counts during the course of 
HIV infection has been recently regarded as a central mechanism to maintain a constant 
level of circulating T cells without regard to the phenotype (CD4 or CD8). This is called 
blind homeostasis (Margolick, 1993; Aldeman, 1993). The net preferential replacement 
of CD4+ cells by CD8+ cells would eventually lead to low levels of CD4+ lymphocytes 
and subsequent immune failure. The failure of blind T cell homeostasis, triggered by the 
decline of CD8+ lymphocytes through apoptotic cell death, has been shown to be a 
precipitating event in the progression to AIDS (Margolick, 1995). Interestingly, in HIV-
infected lymph nodes apoptosis occurs in bystander cells and not in the productively 
infected cells themselves, even though there is a correlation between the amount of 
apoptosis and productive infection (Finkel, 1995). These might suggest that while 
uninfected cells are killed during HIV infection, productively infected cells are relatively 
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resistant to apoptosis. HIV may not kill the cell it infects but rather use it to produce new 
viruses continuously. Taken together, these observations appear to support the view that 
in HIV infection the predominant mechanism of lymphocyte depletion is indirect and 
through the induction of apoptosis. 
Several mechanisms may contribute to the induction of apoptosis in HIV 
infection, including HIV envelope proteins, impaired accessory cell function, 
superantigens and so on. Many of the chemical and physical treatments capable of 
inducing apoptosis are known to evoke oxidative stress. For example, both ionizing and 
ultra-violet radiation are capable of inducing apoptosis, and both generate reactive 
oxygen species (ROS). Recently another oxidant, nitric oxide (NO) has been implicated 
as an inducer of apoptosis in macrophages and monocytes (Albina, 1993). Having a 
single unpaired electron, NO is in itself considered to be a free radical and it also reacts 
with molecular O2 to form O2 and H2O2 (Stamler, 1992). Some apoptosis inducing agents 
are not free radicals themselves, but may elicit ROS formation. Doxorubicin, cisplatin 
and ether-linked lipids are anti-neoplastic agents, which induce both apoptosis and 
oxidative damage in sensitive cells (Benchekroun, 1993; Diomede, 1993; Wagner, 1993; 
Takagi, 1974). Alternatively, oxidative stress can also be induced by decreasing the 
ability of a cell to scavenge or detoxify ROS. For example, drugs such as buthionine 
sulfoxamine deplete intracellular stores of glutathione (GSH), thereby rendering cells 
more susceptible to oxidative stress-induced apoptosis (Zhong, 1993). Evidence that 
apoptosis can be induced by oxidative stress is provided by observations in which 
mediators of apoptosis either induced ROS, or were inhibitable by the treatment of 
antioxidants. Tumor necrosis α (TNFα) is one example of such a mediator. Stimulation 
of the TNF receptor results in a rapid increase in the level of intracellular ROS (Larrick, 
1990; Matthews, 1987) and in various cell types, TNF-mediated apoptosis can be 
inhibited either by thioredoxin, an intracellular thiol reductant and free radical scavenger, 
or N-acetylcysteine (NAC), a thiol antioxidant and GSH precursor (Droge, 1992). 
Moreover, cellular sensitivity or resistance to TNF is correlated with decreased or 
increased levels of superoxide dismutase (SOD), respectively (Hirose, 1993). For 
example, SOD-deficient T cells were known to be more susceptible to killing by TNF, 
ionizing radiation and hyperthermia (Wong, 1991). Hence, the fate of TNF-sensitive cells 
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may depend on the extent of ROS formation and the cells ability to buffer the oxidative 
stress. Several reports suggest the participation of ROS in HIV infection (Harakeh 1990; 
Baruchel, 1992). Virus-infected cells display very low levels of antioxidant defense, such 
as SOD, vitamin E, selenium and glutathione (Baruchel, 1992; Favier, 1994; Buhl, 1989). 
On the other side, patients undergoing HIV infection display high serum levels of 
xanthine oxidase (XOD) (Miesel, 1993) and lipid peroxidation, both markers for 
oxidative stress conditions. Furthermore, opportunistic infection from Mycoplasma can 
accelerate AIDS progression by induction of oxidative stress (Blanchard, 1994). 
Zidovudine or azidothymidine (AZT) is an antiviral drug that stops virus replication by 
interfering the viral reverse transcriptase and inhibit DNA synthesis (Gilman, 1990). 
Interestingly, antioxidants such as N-acetyl cycteine (NAC) and dithiocarbamate 
enhanced the therapeutic effect of zidovudine (Roederer, 1990; Roederer, 1992; 
Resinger, 1990). The mechanism of action may be related to the ability of NAC to restore 
GSH levels and reduce the cytotoxic effect of zidovudine. At a molecular level, the 
transcription of HIV genes is directed by sequences called long terminal repeats (LTR), 
located at the extremities of the viral genome. These elements provide binding sites for 
viral (i.e. tat) and cellular transcription factors (i.e. NFκB). Interestingly, NFκB can be 
strongly activated by ROS and cytokines (i.e. TNFα). This process can be blocked by the 
treatment of antioxidants such as vitamin E, NAC and α-lipoic acid (Thanos, 1995; 
Suzuki, 1992; Suzuki, 1993). HIV-1 acts on the cellular redox system to stimulate its own 
replication and to generate oxidants (Westendorp, 1995). Furthermore, the low levels of 
endogenous antioxidant (Buttke, 1994) and the enhanced production of macrophage-
derived neopterin (Fust, 1995) commonly found in HIV-infected patients also contribute 
to this imbalance and renter cells more susceptible to injury from ROS. It has also been 
reported that HIV Tat may induce lymphocyte apoptosis through down-regulating the 
expression of bcl-2 (De Rossi, 1994). Under this condition the transcription factor NFκB, 
a key element in TNFα  gene expression, is up-regulated (Schulze-Osthoff, 1993; schreck, 
1991). As a consequence, HIV-infected patients have increased production of TNFα 
(Dezube, 1992), which further induces oxidative stress (Hennet, 1993) and stimulates the 
HIV gene expression via the activation of NFκB (Hohmann, 1990; Folks, 1989; Mellors, 
1991). In addition, TNFα can bind its transmembrane receptors and ultimately leads to 
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apoptosis (Kolesnick, 1994; Schutze, 1994; Pushkareva, 1995). Hence the shift to oxidant 
status may enhance the replication of HIV directly and through the induction of TNFα.  
The possible interactions between HIV infection, oxidative stress and TNFα in 
HIV pathogenesis may be depicted as following. During the initial stage, HIV infects 
cells of the immune system, such as macrophages and CD4+ T cells. Then it activates the 
expression of cellular genes including tnf gene. TNFα induces NFκB translocation, 
which acts as a transcription factor to stimulate HIV replication and HIV-Tat production. 
Tat induces oxidative stress which further enhances the activity of TNFα, and CD4+ cells 
incapable of repairing the ensuing oxidative stress are primed to undergo apoptosis. A 
vicious cycle may lead to a steady increase of TNF and Tat and a decrease in antioxidants 
(Famularo, 1997). 
Regulation of ROS levels in mitochondria and or cytoplasm in mammalian cells 
might be mediated by the bcl-2 family gene products (Hockenbery, 1990). Expression of 
the bcl-2 protein prevents the induction of apoptosis by a variety of oxidative stress, 
including ionizing radiation, heat shock or GSH depletion (Zhong, 1993; Hockenbery, 
1990). It has been suggested that the bcl-2 gene product inhibits apoptosis by interacting 
with mitochondria SOD (Itoh, 1993). However, bcl-2 expression can also block apoptosis 
in cells lacking mitochondria (Jacobson, 1993), implying a broader functional distribution 
of the protein. It has recently been shown that various antioxidants (i.e. NAC) can 
substitute for bcl-2 expression in factor-deprived cells from undergoing apoptosis 
(Hockenbery, 1993). From the above evidence, we can see that bcl-2 protein plays a 
crucial role in regulation of apoptotic machinery and could be an indicator of the ability 
of a cell to cope with oxidative stress.  
Intracellular GSH level is an important indicator of the redox buffering capacity 
of the cell. A loss of GSH makes cell more susceptible to oxidative damage. Intracellular 
GSH levels can be artificially lowered in several ways, including withdrawing cysteine 
from the cell culture medium, binding free sulphydryl groups with diethyl maleate or 
inhibiting the glutathione synthase by buthionine sulfoximine (BSO). Normally, lowering 
GSH level alone is insufficient to induce apoptosis. However cells with very low GSH 
levels may be very sensitive to additional stimuli. 
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The PI3-kinase/Akt pathway has recently emerged as an important regulator of 
apoptotic pathways. Bcl-2 family gene product BAD is one of the well-identified targets 
of Akt kinase. PI3-kinase is a family of enzymes capable of phosphorylating 
phosphoinositides in their 3 position. PI3-kinase consists of a regulatory subunit (p85) 
that binds to an activated growth factor/cytokine receptor and undergoes phosphorylation, 
which result in the activation of its catalytic subunit (P110). The product of PI3-kinase, PI 
(3,4,5) P3 or its metabolite PI (3,4) P2, bind to the pleckstin homology (PH) domain of 
Akt/PKB, which causes a conformational change allowing PDK1 (phosphoinositide-
dependent kinase-1) and PDK2 kinases to phosphorylate and activate the Akt/PKB 
kinase, a serine/threonine protein kinase previously implicated in apoptosis suppression 
(Klippel, 1997; Stokoe, 1997; Franke, 1997). A proapoptotic member of Bcl-2 family, 
BAD, was identified as a target of Akt kinase (Mok, 1999). BAD conduct its 
proapoptotic effect by interacting with Bcl-xl and Bcl-2. Akt kinase was able to 
phosphorylate BAD. Phosphorylation of BAD leads to its sequestration by an isoform of 
14-3-3 protein in the cytosol. Bad bound to 14-3-3 is inactive since it can no longer bind 
Bcl-2, resulting in enhanced cell survival (Zha, 1996; Hsu, 1997). Recently, Dr. Reed and 
coworker identified procaspase 9 as another possible target of Akt kinase (Cardone, 
1998), suggesting that Akt kinase can serve as a common antiapoptotic effector and 
regulate the apoptotic pathway at different levels. Since bcl-2 has been shown to play an 
important role in oxidative stress induced apoptosis and Akt kinase is a key regulator of 
bcl-2 levels in cell, it is very worthwhile to investigate the possible role of PI3-kinase/Akt 
pathway in oxidative stress induced cell death. 
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Experimental Procedure 
 
Western Blot 
 
Total cell extracts were prepared and 15µg of protein from each sample was 
separated by 10% SDS-polyacrylamide gel electrophoresis and electroblotted to 
nitrocellulose membrane in a buffer containing 30mM Tris, 200mM glycine and 20% 
methanol. The membranes were blocked by incubation in 1XTBS (10mM Tris HCl 
(PH8.0), 150mM NaCl) with 5% dried milk for 1h at room temperature and then 
incubated at 4°C overnight with primary antibody in 5% milk/TBS. After three 20-min 
washes with 1XTBS, membranes were incubated with secondary antibody conjugated 
with horseradish peroxidase. The reaction was then visualized with the enhanced 
chemiluminescence detection system (ECL) as recommended by the manufacturer 
(Amersham International plc, Buckinghamshire, England). 
 
DNA fragmentation ELISA Assay 
 
DNA fragmentation was quantitated in the cytoplasmic extracts using the cell 
death ELISA kit manufactured by Boehringer Manheim (Indianopolis, IN) using a 
mixture of anti-histone-biotin labeled antibody and anti DNA peroxidase conjugated 
antibody as per the manufacturers instructions.  DNA fragmentation was quantified 
photometrically as a function of nucleosomes released, using ABTS (9,2,2-Azino-di[3-
ethylbenzthiazolin-sulfonate]) as the substrate. 
 
Trypan Blue dye exclusion 
 
To measure viability, cells were stained with trypan blue dye and then the 
numbers of dead and living cells were counted by a previously described method 
(Mclowskey, 1998).   
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DEVDase like activity assay 
 
To measure DEVDase like activity, cytoplasmic extracts were prepared and 
analyzed using the CASPASE 3 Cellular Activity Assay Kit PLUS  (BIOMOL Research 
Laboratories, Inc. 5100 Campus Drive Plymouth Meeting, PA-19462).  
 
DNA Fragmentation Analysis by Gel Electrophoresis  
 
To measure DNA fragmentation qualitatively, cells were lysed and DNA isolated 
via a method that has been described earlier (42).  Briefly, the cells were solubilized in a 
lysis buffer (10mM Tris pH 8.0, 100mM NaCl, 25mM EDTA, 0.5% SDS and 400mg/ml 
Proteinase K and incubated overnight at 37°C.  The samples were then extracted three 
times with an equal volume of phenol: chloroform: isoamyl alcohol (25:24:1) followed 
by a chloroform extraction.  The DNA was precipitated in the presence of 0.3M NaOAc 
(pH 5.2) and 10mM MgCl2 with three volumes of EtOH.  The precipitated DNA was 
resuspended in dH20, treated with RNAse A (10 mg/ml) for one hour at 37°C, re-
extracted and precipitated.  The concentration of DNA was quantitated by UV 
absorbance at 260 nm.  Ten micrograms of DNA were analyzed by gel electrophoresis on 
a 1. 6 % agarose gel, and visualized by staining with 0.4 µg/ml Ethidium Bromide. 
 
Akt-kinase activity assay 
 
Stimulated cells were collected and lysed in lysis buffer (PBS pH 7.4, 1% NP-40, 
200 µM sodium orthovanadate, 0.1 mg/ml phenylmethylsulfonyl fluoride (PMSF), 10 
µg/ml aprotinin, 10 µg/ml leupeptin, 4 µg/ml benzamidine, 50 mM potasium fluoride, 
1mM β-glycerophosphate, 5 mM sodium pyrophosphate, 1µM okadaic acid) and 
centrifuged at 15,000g for 10 min at 4 °C. Supernatants were incubated for 2 hr at 4 °C 
with 10-20 µg of goat anti-PKB antibody conjugated protein G-agarose. 
Immunoprecipitates were washed in lysis buffer and three times in assay buffer (20 mM 
MOPS pH 7, 25 mM β-glycerophosphate, 5 mM EDTA, 1 mM sodium orthovanadate, 1 
mM dithiothreitol). The final agarose pellets were resuspended in assay buffer and 
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incubated with Akt substrate in assay buffer. The reaction is started by adding 10 µ Ci 
[32P]-ATP diluted with 0.5 mM cold ATP and the samples were incubated for 15 min at 
37°C. Equal amount of supernatant was transferred to Pierce Phosphocellulose Unit and 
washed 3 times by Pierce binding buffer. The membrane portion of the Unit was counted. 
 
MTT assay 
 
Cell survival was measured using the MTT (3, (4,5-dimethylthiazol-2-yl) 2,5-
diphenyltetrazolium bromide) assay as described by Hansen et al. (113). Briefly, the cells 
were seeded onto 96-well culture plates at a density of 20,000 cells/100µl medium per 
well. After treatment of the cells, 25 µl of a 5 mg/ml stock solution of MTT was added to 
each well, and incubated at 37 °C for 2 hrs to allow cells to take up the dye and convert it 
to the formazan derivative. The formazan was solubilized by the addition of 100 µl of 
lysis buffer (20% SDS in 50 % DMF, pH 4.7), and optical density was measured after a 
24 hrs incubation at 37 °C using a Dyna Tec-700 plate reader. 
 
Measurement of GSH level 
 
Cells are seeded at 2 × 105 in 6-cm Petri dishes in 4 ml of complete medium. Two 
days later, cells are treated with the desired agents as described above. Treated cells are 
detached by trypsinization, washed (three times) with ice-cold PBS, and solubilized in 
150 µl of water. 5-Sulfosalicylic acid is added to a final concentration of 2%, and the 
supernatant is separated from the acid-precipitated proteins by centrifugation. GSH 
content in the supernatant was determined by the Griffith modification of the Tietze's 
enzymatic procedure as described (Liu, 1997). Protein content is determined by the dye 
binding assay using bovine serum albumin as standard. 
 
Alamar Blue Assay 
 
Alamar Blue is a cell growth and cytotoxicity indicator dye and considered to be 
good replacement for MTT. Plate cells on 96 well tissue plate in final volume of 1 ml. 
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When treatment time is done. Add 100µl Alamar Blue and incubate for 2h. Read it on 
any microplate spectrophotometer or fluoromater (Fluorescence with excitation at 560nm 
and emission at 590nm; Absorbance with excitation at 570nm and absorbance at 600nm) 
 
LDH Release Assay 
 
Lactate Dehydrogenase catalyzes the interconversion of lactate and pyruvate. After 
treatment, collect culture media. Add 0.05ml sample and 1ml LD-L reagent. Mix well 
and read the absorbance  at 340nm  using a spectrophtometer every minute up to 5 times. 
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Results 
 
Inhibition of PI3-kinase/Akt-kinase pathway induces cell death in CD4+ T cell line  
 
PI3kinase/Akt have been shown to be an important anti-apoptotic pathway. 
Overexpression of constitutively activated forms of PI3kinase or Akt-kinase result in 
decreased apoptosis in response to serum/growth factor deprivation, UV-B irradiation, or 
loss of matrix attachment (Kauffmann-Zeh, 1997; Kennedy, 1997; Khwaja, 1997). First, 
we investigated whether inhibition of PI3kinase/Akt pathway without any further stimuli 
is sufficient for CD4+ T cells to undergo apoptosis. We treated Jurkat cells with two 
structurally unrelated specific PI3kinase inhibitors, LY294002 (LY) and wortmannin 
(WT) respectively. After three hours, the activity of Akt kinase was evaluated. Cell lysate 
was immunoprecipitated with Akt antibody. Then substrate of Akt kinase was applied to 
the immunoprecipitates to evaluate the activity of Akt kinase. In Fig. 21, we can see that 
both LY and WT inhibit Akt kinase activity in a dose-dependent fashion. Cell survival 
was measured by MTT assay after twelve hours of treatment. We found that LY and WT 
dose-dependently induce cell death in Jurkat T cells (Fig. 22). 
 
Inhibition of PI3-kinase/Akt-kinase pathway sensitizes cells to undergo apoptosis. 
 
After examining the effect of PI3-kinase inhibitor on cell viability, we further 
studied its effect on apoptotic signaling. Jurkat cells were treated with increasing 
concentrations of LY294002 for 5h. Cytoplasmic extracts were isolated and assayed for 
(I) activity of caspase-3, which is a hallmark of apoptosis, using caspase-3 specific 
tetrapeptide substrate Ac-DEVD-AMC (7-amino-4-trifluoromethyl coumarin) as a 
fluorogenic substrate (II) protein level of caspase3 by western blot and (III) DNA 
fragmentation using an antihistone DNA ELISA kit. Data are normalized to untreated 
values. We found that inhibition of PI3-kinase/Akt-kinase pathway by LY294002 induces 
caspase-3 activity as documented by a dose-dependent increase in DEVD-ase activity 
(Fig. 23) and a decrease in the protein level of 32 kd procaspase 3 (Fig. 24). Also 
LY294002 elicited DNA fragmentation in a dose-dependent fashion (Fig. 25). These data  
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Figure 22. LY294002 and Wortmannin, two specific and structurally
distinct PI3-kinase inhibitors dose-dependently induced cell death in CD4+
T cells. Jurkat cells were seeded on 96-well plate and treated with
increasing concentrations of LY 294002 (5, 10, 15, 25, 50, 100µM in A)
and  Wortmannin (0.1,0.5,1,1.5,2,3 µM, in B) for 5 hrs. Cell viability was
measured by MTT assay.
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Figure 23. LY294002 dose-dependently induces caspase 3
activity. Cells were treated with increasing concentrations of
LY 294002 (5, 10, 15, 25, 50 µM). Cells were harvested and
cytoplasmic extracts were prepared for caspase3 activity assay.
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Figure 24. LY294002 dose-dependently induces proteolysis of
procaspase 3. Cells were treated with increasing concentrations of
LY 294002 (5, 10, 15, 25, 50, 75, 100µM). Cells were harvested
and total cell extracts were prepared for Western Blot analysis
with antibody specific for procaspase 3
CPP32
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Figure 25. LY294002 dose-dependently induced DNA fragmentation
in Jurkat cells. Cells were treated with increasing concentrations of
LY 294002 (5, 10, 15, 25, 50µM), and harvested. Cytoplasmic
extracts were prepared and analyzed by Cell Death ELISA.
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showed that inhibition of PI3-kinase/Akt-kinase pathway induces apoptotic signaling and 
eventually leads to apoptotic cell death. 
 
Oxidative stress induces apoptosis in CD4+ T cells. 
 
Many agents, which induce apoptosis, are either oxidants or stimulators of 
cellular oxidative metabolism. Conversely, many inhibitors of apoptosis have antioxidant 
activities or enhance cellular antioxidant defenses. Mammalian cells exist in a state of 
oxidative siege in which survival requires an appropriate balance of oxidants and 
antioxidants (Buttke, 1994). Hydrogen peroxide (H2O2) is a well-known oxidant and has 
been shown to induce apoptosis (Lennon, 1991) and NFκB activation (Schreck, 1991) in 
a variety of cell types. Therefore we chose H2O2 as the stimulator to investigate the 
interaction of oxidative stress induced apoptosis and PI3-kinase/Akt-kinase pathway. 
Jurkat T lymphocytes were exposed to increasing concentrations of H2O2 for 12h. Then 
cell viability was determined by trypan blue exclution (Fig. 26) and alamar blue analysis  
(Fig. 27). We found that in the dose range from 100µM to 500µM, H2O2 caused 
significant loss of cell viability in a dose-dependent pattern. Caspases are a novel class of 
cysteine proteases, which are activated during apoptosis by proteolytic processing at 
specific aspartate cleavage sites (Kim, 2000). Among more than 10 caspases identified so 
far, caspase-3, a member of DEVD-specific caspases (DEVDase), has received particular 
attention because it is commonly activated by a broad range of apoptotic stimuli. So in 
the next step, we evaluated the activation of caspase-3 in H2O2 induced apoptosis in 
Jurkat T cells. Cells were treated with H2O2 at increasing concentrations from 25 to 
500µM for 6h. Cytoplasmic extracts were prepared and DEVDase activity was measured 
by its ability to hydrolyze a specific peptide substrate. We showed that H2O2 at 100µM 
significantly induced caspase-3 activity and this effect was further augmented by higher 
concentrations (Fig. 28). 
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Figure 26. Oxidative stress induced cell death in CD4+ T
cells. Jurkat cells were treated with increasing concentrations
of H2O2 for 12h. Cell viability  was evaluated by Trypan Blue
exclusion.
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Figure 27. Oxidative stress induced cell death in CD4+
T cells. Jurkat cells were treated with increasing
concentrations of H2O2 for 12h. Cell viability
was evaluated by Alamar Blue Assay.
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Figure 28. H2O2 dose-dependently induces caspase 3 activity.
Cells were treated with increasing concentrations of H2O2.
Cells were harvested and cytoplasmic extracts were prepared
for caspase 3 activity assay.
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Hydrogen Peroxide induced apoptosis involves loss of Akt-kinase  
 
Akt-kinase is a key antiapoptotic regulator. Earlier we have shown that inhibition 
of PI3-kinase/Akt-kinase pathway without any other stimuli could lead to apoptosis in 
Jurkat T lymphocytes. Next we were curious to see what happened to Akt-kinase in H2O2 
induced cell death. Jurkat cells were either untreated or treated with H2O2 at 100, 250 and 
500µM respectively. Cells were collected at four different time points, namely 3h, 6h, 
12h and 24h. Total cell lysates were prepared and evaluated by western blot (Fig. 29, 30). 
Two antibodies were used. One can specifically recognize phospho-Akt, the active and 
functional form of Akt-kinase. The other can react with both wild type Akt 
(unphosphrylated) and phospho-Akt. At 3h, we found that H2O2 at 100µM did not affect 
the level of phospho-Akt. However, H2O2 at 250 and 500µM cause significant loss of 
phospho-Akt in a dose-dependent pattern (Fig. 29). If comparing the levels of phospho-
Akt with the same concentration of H2O2 treatment at different time points, we can 
clearly see that phospho-Akt further went away along with the prolonged treatment time 
(i.e. in Fig. 29, compare between Lane 2,6,10 and 14). Its level was almost undetectable 
after 6h with the concentration of H2O2 at 250 and 500µM respectively. As shown in Fig. 
30, the level of total Akt (phospho-and wildtype) is roughly unchanged over the first 6 
hours. The 12h and 24h treatments show a downregulation of total Akt level. 
Pretreatment of cells with DEVD-cho, a peptide inhibitor for caspase 3, was unable to 
rescue Akt inactivation (Fig. 31). We will further discuss these observations in the 
discussion section.  
 
N-acetyl-cycteine rescues CD4+ T lymphocyets from hydrogen peroxide induced 
apoptosis while GSH depletion enhances it. 
 
GSH is the predominant thiol present in many cells, and its presence seems to be a 
prerequisite for protection against oxidative damage. We proposed that depletion of GSH 
may sensitize cells to oxidative stress induced apoptosis. We pretreated cells with 2.5mM 
BSO, which is known to lower the intracellular GSH level by inhibiting its biosynthesis.  
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Figure 29. Time course of oxidative stress induced phospho-Akt (P-Akt)
downregulation. Cells were treated with increasing concentrations of H2O2..
Total cell lysates were evaluated using antibody specific for P-Akt.
Lane Number               1                2                3                 4                5               6               7             8
Time (hour)                  3                3                3                 3                6               6               6              6
H2O2  (µM)                   -              100            250             500               -             100            250         500
Lane Number               9              10             11             12                           13            14           15          16
Time (hour)                 12             12             12             12                           24            24           24          24
H2O2  (µM)                   -              100           250           500                           -             100         250       500
P-Akt
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Lane Number   1                2               3                4                5                 6                7               8
Time (hour)      3                3               3                3                 6                6                6               6
H2O2  (µM)       -               100           250             500             -               100            250          500
Lane Number    9                 10               11               12              13              14              15             16
Time (hour)      12                12               12               12              24              24              24             24
H2O2  (µM)         -                100             250             500              -               100            250           500
Figure 30. Time course of oxidative stress induced Akt downregulation.Cells
were treated with increasing concentrations of H2O2.. Total cell lysates were
evaluated using antibody recognizing both P-Akt and Akt.
Akt
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Figure 31. H2O2 induced P-Akt downregulation may be caspase 3
independent. Cell were treated with H2O2 in the presence or absence of
DEVD-cho. Total cell lysates were analyzed by western blot.
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We showed that the GSH levels were significantly depleted after treating with BSO (Fig. 
32). With or without BSO pretreatment for 12h, Jurkat cells were exposed to increasing 
concentrations of H2O2 from 25 to 500µM for another 12h. LDH release assay was 
performed to evaluate cell viability (Fig. 33). The LDH activity in the culture medium 
correlates with the extent of cell death. Without BSO pretreatment H2O2 induced 
moderate to substantial cell death at 250 and 500µM. There is no significant cell death 
observed at low dose range from 25 to 100µM. However, with BSO pretreatment, the 
effect of H2O2 induced cell death is greatly and synergistically enhanced. Even low dose 
H2O2 can induce substantial amount of cell death. NAC is a well-known antioxidant and 
is a precursor for GSH biosynthesis. To study its potential protective effect on H2O2 
induced apoptosis, we exposed cells to increasing concentrations of H2O2 with or without 
the pretreatment of 2.5mM NAC for 6h (Fig. 34). Cell death was examined by LDH 
release assay. As expected, NAC pretreatment completely blocked H2O2 induced cell 
death. At the same time, cytoplasmic extracts were prepared for measurement of caspase-
3 activity after 6h exposure to H2O2 at 100 and 250µM. In Fig. 35, NAC pretreatment 
significantly down-regulated H2O2 induced caspase-3 activation.  
 
In summary, the above results demonstrate that oxidative stress can strongly 
induce caspase 3 activation and apoptosis in CD4+ T lymphocytes. Depletion of 
intracellular GSH by BSO enhanced oxidative stress induced apoptosis, while antioxidant 
NAC suppress it. Akt kinase is an important antiapoptotic factor and indispensable for the 
survival of CD4+ T lymphocytes. Inactivation and further degradation of Akt kinase is 
involved in oxidative stress induced cell death. 
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Figure 32. Depletion of GSH level by BSO. Cells were treated with BSO at
2.5mM and harvested at several time points (O/N overnight). Intracellular 
GSH levels were measured by HPLC. 
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Figure 33. BSO sensitizes Jurkat cells to H2O2 induced cell death.
Cells were treated with increasing concentrations of H2O2 for 24h
with/without BSO pretreatment at 2.5mM for 12h. Cell death is
evaluated by LDH release assay.
LD
H
 A
ct
iv
ity
 99
  
 
0
0.005
0.01
0.015
0.02
0.025
0.03
0.035
0.04
U
T
H
2O
2 2
50
H
2O
2 5
00
N
A
C
 2
.5
+ 
H
2O
2 2
50
N
A
C
 5
.0
+ 
H
2O
2 2
50
N
A
C
 5
.0
+ 
H
2O
2 5
00
N
A
C
 2
.5
+ 
H
2O
2 5
00
N
A
C
 2
.5
N
A
C
 5
.0
Figure 34. NAC rescues Jurkat cells from H2O2 induced cell death. 
Cells were treated with increasing concentrations of H2O2 for 24h 
with/without NAC pretreatment at 2.5 and 5.0mM for 12h. Cell 
death is evaluated by LDH release assay.
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Figure 35. NAC inhibits H2O2 induced caspase 3 activity. Cells were
treated with increasing concentrations of H2O2 for 6h with/without NAC
pretreatment. Cells were harvested and cytoplasmic extracts were
prepared for caspase3 activity assay.
 101
  
 
Discussion 
 
Human immunodeficiency virus (HIV) infection is considered to lead to full-
blown acquired immunodeficiency syndrome (AIDS) through a progressive and complete 
loss immune competence in the infected host. Recent research has highlighted that HIV 
may trigger an active cell suicide process, termed programmed cell death or apoptosis, 
that contributes to the decline in lymphocyte count throughout the course of the infection. 
The most important difference between apoptosis and necrosis is of a functional nature. 
The active cell suicide process requires activation signals, signal transduction, and 
sometimes gene expression as well as RNA and protein synthesis in the dying cell. In 
general, the apoptotic process is associated with a breakdown of intracellular calcium 
homeostasis, cytoplasm condensation, disruption of cytoskeleton, DNA fragmentation, 
activation of endonucleases and proteases and phagocytosis (Bursch, 1990; Kroemer, 
1995). Apoptosis presents morphological characteristics differing from cell necrosis, 
which is capable of inducing inflammatory responses. It has been suggested that the 
disruption of the balance between cell proliferation and cell death could be implicated in 
several pathological disorders. For example, cancer could be considered as a result of 
excess of cell proliferation or inhibition of cell death, while degenerative diseases may 
result from excess of cell death or activation of apoptosis. Taking this assumption into 
account, AIDS can be considered as a disease associated with excessive death of CD4+ T 
cells (Weiss, 1993). Various agents appear to be able to trigger apoptosis in CD4+ T 
lymphocytes, including viral proteins (i.e. gp120, Tat), inappropriate secretion of 
inflammatory cytokines (i.e. TNFα) and toxins produced by opportunistic micro-
organisms. Since oxidative stress can also induce apoptosis, it has been suggested that 
such a mechanism could participate in CD4+ T cell apoptosis observed in AIDS 
(Harakeh, 1990). This correlates strongly with the observation that AIDS patients present 
low levels of antioxidants most likely due to inappropriate nutrition, alcohol and drug 
consumption, and digestive problems associated with the disease. Furthermore, 
coadministration of the antiviral drug with antioxidants increases its therapeutic potential 
(Roederer, 1990; Roederer, 1992; Reisinger, 1990; Hersh, 1991). The above facts 
suggested that oxidative stress induced apoptosis in CD4+ T cells could play a critical 
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role in HIV pathogenesis, however, the underlying mechanisms still remain to be 
elucidated. Protein kinase B (PKB)/Akt has been increasingly linked to enhanced cell 
survival. PKB is activated downstream of phosphoinositide 3-kinase (PI3K) in a wide 
range of signaling cascades including those for growth and survival factors (Marte, 
1997). In the present study, we evaluated the possible involvement of PI3K/Akt pathway 
in oxidative stress induced apoptosis. First, we showed that PI3K/Akt pathway is 
indispensable for the survival of CD4+ T cell line. Jurkat cells were treated with two 
structurally distinct PI3-kinase inhibitors, LY294002 and Wortmannin, both of which can 
effectively and specifically inhibit PI3-kinase activity and consequently block the 
downstream Akt kinase activity (Fig. 21). MTT assay (Fig. 22) and DNA fragmentation 
ELISA (Fig. 25) showed decreased cell viability and increased DNA fragmentation in 
response to the two inhibitors in a dose-dependent fashion. Caspase 3 activation, one of 
the hallmarks of programmed cell death, was enhanced in Jurkat cells treated with either 
PI3-kinase inhibitors (Fig. 23, 24). In summary, this study suggests that PI3-kinase/Akt 
pathway is critical for the survival of CD4+ T cells. Then, we moved on to study the 
effect of oxidative stress on the survival of CD4+ T cells. Jurkat cells were treated with a 
known oxidant, hydrogen peroxide. As expected, H2O2 induced cell death dose-
dependently (Fig. 26, 27). Further, the characteristic apoptotic signal, caspase-3 
activation, was evaluated and found greatly elevated in H2O2 induced cell death (Fig. 28). 
This confirmed that apoptotic mechanism is actively involved in oxidative stress related 
cell death. One novel finding of this study was that multi-level anti-apoptotic effecter 
PKB/Akt was down regulated in H2O2 induced apoptosis. The Akt kinase was known to 
phosphorylate a proapoptotic bcl-2 family member bad and maintain the integrity of 
mitochondria. It has been shown to phosphrylate caspase-9 leading to a reduction in the 
protease activity of this caspase and blocking of the further relay of apoptotic signaling 
(Cardone, 1998). A recent study has also revealed that PKB can inhibit apoptosis by 
phosphrylating and inhibiting the Forkhead transcription factor FKHRL1 (Brunet, 1999), 
which is then sequested in the cytoplasm in association with 14-3-3 proteins. This results 
in blocking FKHRL1 mediated transcription of death-inducing genes such as Fas ligand, 
with obvious implications for the apoptotic program. Clearly PKB is able to act at several 
points along the apoptotic cascade. This is unlikely to represent functional redundancy. 
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Since apoptosis is a multistep process, the multiple actions of PKB make it more efficient 
and effective on blocking the apoptotic machinery. Therefore, it is very natural to take 
out this anti-apoptotic force in order to commit the cell to death. Our result showed that 
in the early phase (0-6h after H2O2 treatment) of apoptosis only the phospho-Akt level 
(Fig. 29) was reduced while the total Akt level (Fig. 30) was roughly unchanged. 
However, in the late stage (12h after H2O2 treatment and later) the total amount of Akt 
kinase is also significantly dropped. Similar to the result from chapter 3, the inactivation 
of Akt seems caspase 3 independent (Fig. 31), again implicating that PI3K/Akt pathway 
primarily functions in the early stage of apoptosis. We can try to speculate that in the 
early stage of apoptosis in H2O2 treatment in Jurkat cells the PKB proteins were mostly 
inactivated or unphosphorylated to their inactive form. If this is true, it implicates that at 
this phase the apoptotic process is probably reversible. If appropriate intervention takes 
place, the apoptotic process can be stopped and cell can be rescued. It may be a good 
potential therapeutic window to let clinical interventions come in and turn things around. 
However, in the late phase of apoptosis, the cells are determined to die, the 
endonucleases and certain protease started to chop off DNA and other protein targets 
possibly including Akt. Secondary necrosis could also be involved in this process. Last 
but not least, we found that depletion of GSH greatly sensitized cells to H2O2 induced cell 
death (Fig. 33). Antioxidant NAC pretreatment protected Jurkat cells from H2O2 
associated caspase 3 activation (Fig. 35) and cell death (Fig. 34). This supports the fact 
that antioxidant coadministration is usually beneficial to oxidative stress involved disease 
processes (i.e. AIDS). 
Taken together, in this study, we investigated oxidative stress induced apoptosis 
and importantly the involvement of PI3K/Akt, a common anti-apoptotic pathway, in this 
process in CD4+ T cells. We demonstrate that in Jurkat T lymphocytes hydrogen peroxide 
is able to activate caspase signaling cascade leading to DNA fragmentation and 
apoptosis. Importantly, Akt kinase is significantly and dose-dependently down-regulated 
in H2O2 induced cell death. Pretreatment of antioxidant NAC can make cells resistant to 
H2O2 treatment and depletion of GSH by BSO sensitize cells to it. 
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Chapter Five 
 
Summary 
 
The human immunodeficiency virus (HIV-1) was first identified in 1983 (Barr-
Sinoussi, 1983) and is now considered as the cause for the progressive immune system 
degeneration leading to the development of AIDS. HIV-1 infection is transmitted 
sexually, through intravenous contact with contaminated blood, or across broken mucosal 
or epidermal epithelia. HIV-1 can also be transmitted vertically from infected mothers in 
utero or through lactation after birth (McCune, 1991). The typical course of HIV-1 
disease begins with a primary infection followed by an acute viral syndrome 
characterized by a mononucleosis-like illness, generalized lymphadenopathy, intense 
plasma viremia, and a significant decrease in circulating CD4+ T cells approximately 3 to 
6 weeks after the initial infection. This is followed by extensive viral dissemination to 
surrounding tissues such as lung, bone marrow and liver but particularly to the lymph 
nodes (Pantaleo, 1993). Then as a result of an immune response specifically against HIV-
1, the acute syndrome resolves, the number of circulating CD4+ T cells recovers, and the 
infection may enter a period of clinically latency that can last for 10 years or even longer. 
During this period, HIV-1 persists in the lymphoid tissue, where it continues to replicate 
and infect circulating T cells. During this phase, virus is replicated and destroyed at a 
very high rate, and so do CD4+ T cells. Such a dynamic replication rate yields an 
extremely high mutation rate (Ho, 1995). The result, over a time course of years, is the 
net decline in the number of CD4+ T cells and the gradual deterioration of multiple 
aspects of immune responses. In later stage of HIV-1 desease or AIDS, virus is usually 
detectable in the peripheral blood because of the breakdown in the ultrastructure of 
lymph nodes that permits virus to escape into the circulation. Because of the extremely 
low level of circulating CD4+ T cells, patients may become increasingly susceptible to 
life-threatening opportunistic infections and malignancies (Fauci, 1993). 
 
The course of HIV/AIDS disease is a course of progressive degeneration of the  
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immune system. At the primary infection stage, the HIV-1 specific immune response is 
pretty effective and is able to clear most of the virus in the body and drastically restore 
the number of CD4+ T cells. Unfortunately, the HIV seems smart enough to find a way to 
escape from a total elimination and keep replicating and infecting CD4+ cells. The 
immune system tries very hard to hold itself by replenishing CD4+ T cells and clearing 
virus at very high rate until running out of fuel. This rather long latency period presents 
a great opportunity for therapeutic interventions. Intense amount of investigation and 
research have been and are being undertaken to unveil the underlying mechanisms and 
design potential therapeutic strategies.  
 
During the latent phase of human immunodeficiency virus type 1 (HIV-1) 
infection, CD4+ T cells carrying replication competent proviral HIV-1 DNA play an 
important role in persistence of the virus. Several cofactors can induce and or amplify 
HIV-1 replication and negatively impact disease progression and pathogenesis. Ethanol 
consumption is an important risk factor for HIV-1 infection and has been implicated it 
may adversely affect HIV-1 replication and disease progression. Since TNFα  is an 
important modulator of HIV-1 replication, we investigate the possible effects of ethanol 
on TNFα inducible signaling associated with HIV-1 replication in human CD4+ T cells 
(Jurkat E6-1). We demonstrate that clinically relevant ethanol concentrations 
significantly potentiate TNFα inducible NFκB.  Although ethanol effectively 
collaborated with TNFα, by itself it does not have a direct effect on NFκB activation. 
The ethanol dependent potentiation of TNFα inducible NFκB nuclear translocation is 
observed to involve the enhanced degradation of IκBα.  Additionally, the ethanol 
mediated potentiation of TNFα inducible NFκB activation, is abrogated by the known 
antioxidant pyrrolidinedithiocarbamate (PDTC), suggesting an important mechanistic 
role for reactive oxygen species (ROS) in this process. In correspondence with its effect 
on NFκB, ethanol is also able to significantly enhance HIV-1 long terminal repeat (HIV-
1-LTR) dependent transcription induced by TNFα.  Overall, the data provides a 
molecular basis for the possible role of ethanol as a cofactor that can adversely affect 
HIV-1 infection and pathogenesis. 
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Apoptosis, also known as programmed cell death (PCD), is an active cell suicide 
process and has long been recognized as an important feature in embryonic development, 
in particular in shaping the immune and nervous systems. In the early 1990s, it was 
proposed that inappropriate induction of apoptosis may play a central role in HIV/AIDS 
pathogenesis. Most immunological and nonimmunological defects leading to AIDS, 
including severe conditional infection, brain atrophy and dementia, could be related to an 
activation induced suicide process in CD4+ T cells and neurons, caused by indirect 
interference of HIV with inter- or intracellular signaling. Sphingomyelin lipid is 
structural component of the plasma membrane of eukaryotic organisms. Its breakdown 
product, ceramide, has been shown to exert potent apoptotic effect in a variety of cell 
types. In HIV-infected patient, intracellular ceramide levels has been significantly 
elevated in CD4+ and CD8+ T cells, which displayed markedly increased apoptosis 
compared to a normal population (Dimarzio, 1997; Cifone, 1997). Hence, it is very 
relevant to examine the mechanism of ceramide induced apoptosis in CD4+ T cells. In the 
current study, we treat human CD4+ T cell line Jurkat E6-1 with cell-permeable short-
chain ceramide and evaluate two characteristic apoptotic markers, caspase 3 activaty and 
DNA fragmentation. As expected, ceramide potently induces caspase 3 activity and DNA 
fragmentation in a dose-dependent pattern. Pretreatment with Zn2+ is able to almost 
completely rescue ceramide induced DNA fragmentation. Interestingly, caspase 3 is 
identified as a noval target of zinc. Zinc significantly suppress the activity of caspase 3 
while the processing from procaspase 3 to active caspase 3 is unaffected by zinc. We 
have also found that the Fas ligand protein level is significantly increased in ceramide 
induced apoptosis in CD4+ T cell line Jurkat. We speculate this could serve as a positive 
feedback to further exacerbate the apoptotic effect of ceramide. This effect seems to be 
caspase 3 dependent because it is blocked by a DEVDase specific inhibitor, DEVD-cho. 
This implies that caspase 3 may play a role in the regulatory phase of apoptosis rather 
than traditionally being considered just as an executor.  
 
A coin has two sides. Similarly, the survival of cell is under tightly regulation by 
both apoptotic pathway and its counterpart, antiapoptotic pathway. Recently, PI3K/Akt 
pathway has emerged as a common survival pathway. That how this pathway is involved 
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in the process of CD4+ T cells apoptosis is our motivation to conduct the following 
research. First, in ceramide induced apoptosis, we have found that the PKB/Akt activity 
is greatly down-regulated. Pretreatment of DEVD-cho can not restore the Akt kinase 
activity, indicating that this process is caspase 3 independent. This result is in 
concordance to the fact that Akt/PKB has been suggested to function upstream of caspase 
3 activation  
 
Oxidative stress has long been proposed as a mediator of apoptosis in CD4+ T 
cells in HIV pathogenesis. The current study has evaluated the role of PI3K/Akt pathway 
in the context of oxidative stress induced cell death in CD4+ T cells. Without further 
stimuli, Jurkat cells treated with PI3K specific inhibitors underwent significant caspase 3 
activation and massive cell death. This result confirms that the PI3K/Akt pathway is 
essential for the survival of CD4+ T lymphocytes. A known oxidant hydrogen peroxide 
from 100 to 500µM is also able to activate caspase cascade and further lead to DNA 
fragmentation and apoptosis. More importantly, Akt kinase activity is significantly and 
dose-dependently down-regulated in H2O2 induced cell death. Pretreatment of antioxidant 
NAC can rescue cells from H2O2 induced caspase 3 Activation and apoptosis, while 
depletion of GSH by BSO exacerbate H2O2 induced cell death. Recent report shows that 
the extracellular HIV-1 Tat protein can activate PI3K/Akt pathway in Jurkat cells (Paola, 
1997), implicating that this pathway is truly ubiquitous and may be a future target for 
potential therapeutic strategies for disorders associated with excessive cell death (i.e. 
AIDS). 
 
Taken together, HIV/AIDS is a major worldwide epidemic disease and has killed 
millions of people since it was first reported in the early 1980s. Two major aspects in 
HIV pathogenesis are virus replication and depletion of CD4+ T cells. The current study 
provides molecular basis for the adverse effect of ethanol on latency HIV replication and 
in-depth insight into the possible mechanisms underlying CD4+ T cell apoptosis. This 
work along with many others will help to generate future therapeutic strategies to battle 
diseases such as HIV/AIDS that are devastating to the individuals afflicted and an 
enormous economic burden for this world. 
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